patient_id string | sex string | race_ethnicity string | geographic_region string | residence_type string | socioeconomic_status string | primary_language string | insurance_type string | primary_disease_category string | disease_class string | orpha_code int64 | omim_number int64 | inheritance_pattern string | disease_severity_index float64 | expected_mortality_by18_untreated float64 | age_at_symptom_onset_yrs float64 | age_at_diagnosis_yrs float64 | diagnostic_delay_years float64 | prior_misdiagnoses_count int64 | specialists_seen_count int64 | pcp_visits_count int64 | er_visits_pre_diagnosis int64 | hospitalization_pre_diagnosis int64 | newborn_screening_eligible int64 | newborn_screening_caught int64 | newborn_screening_age_at_flag_days float64 | genetic_test_modality string | time_to_genetic_test_months float64 | genetic_test_insurance_denial_flag int64 | genetic_test_cost_usd int64 | pathogenic_variant_confirmed int64 | diagnosis_source string | diagnostic_odyssey_cost_usd float64 | parent_self_advocacy_score float64 | developmental_milestones_status string | gross_motor_quotient float64 | fine_motor_quotient float64 | expressive_language_quotient float64 | receptive_language_quotient float64 | cognitive_quotient float64 | autism_spectrum_comorbid_flag int64 | adhd_comorbid_flag int64 | seizure_flag int64 | seizure_onset_age_yrs float64 | seizure_medications_count int64 | cardiac_involvement_flag int64 | lvh_severity string | respiratory_involvement_flag int64 | fvc_pct_predicted float64 | niv_use_flag int64 | tracheostomy_flag int64 | gi_involvement_flag int64 | g_tube_flag int64 | hepatic_involvement_flag int64 | renal_involvement_flag int64 | ophthalmologic_involvement_flag int64 | hearing_loss_flag int64 | skeletal_involvement_flag int64 | short_stature_zscore float64 | bmi_zscore float64 | plasma_amino_acids_abnormal int64 | urine_organic_acids_abnormal int64 | acylcarnitine_profile_abnormal int64 | urine_gag_elevated int64 | chitotriosidase_u_l float64 | lyso_gb1_ng_ml float64 | lyso_gb3_ng_ml float64 | gaa_activity_nmol_hr_mg float64 | gla_activity_nmol_hr_mg float64 | ammonia_umol_l float64 | lactate_mmol_l float64 | pyruvate_mmol_l float64 | ck_u_l float64 | ldh_u_l float64 | ast_u_l float64 | ferritin_ng_ml float64 | soluble_il2r_u_ml float64 | orphan_drug_available_for_condition int64 | treatment_received string | ert_product string | gene_therapy_product string | aso_product string | small_molecule_product string | treatment_start_age_yrs float64 | treatment_delay_from_dx_months float64 | treatment_cost_annual_usd float64 | payer_coverage_status string | appeal_submitted_flag int64 | appeal_success_flag int64 | time_to_treatment_access_months float64 | patient_assistance_program_enrolled_flag int64 | copay_out_of_pocket_annual_usd float64 | icer_value_assessment string | qaly_estimate_per_year float64 | treatment_adherence_pct float64 | infusion_reaction_flag int64 | antidrug_antibody_flag int64 | treatment_efficacy_response string | hsct_performed_flag int64 | hsct_donor_type string | hsct_gvhd_flag int64 | hsct_engraftment_success_flag int64 | disease_progression_velocity string | hospitalization_annual_count int64 | hospitalization_days_annual int64 | metabolic_crisis_count int64 | icu_admission_flag int64 | respiratory_failure_event_flag int64 | ambulation_status_age18 string | communication_status_age18 string | g_tube_dependent_age18 int64 | ventilator_dependent_age18 int64 | school_placement string | iep_504_plan_flag int64 | therapies_received_count int64 | mortality_flag int64 | age_at_death_yrs float64 | cause_of_death string | hospice_palliative_care_flag int64 | caregiver_zarit_score float64 | caregiver_phq9_score float64 | caregiver_gad7_score float64 | caregiver_employment_disruption_flag int64 | caregiver_lost_income_annual_usd float64 | caregiver_sleep_hours_per_night float64 | household_out_of_pocket_annual_usd float64 | ped_qol_total float64 | ped_qol_physical float64 | ped_qol_emotional float64 | ped_qol_social float64 | ped_qol_school float64 | sibling_impact_score float64 | marital_strain_flag int64 | divorce_separation_flag int64 | parent_advocacy_group_member_flag int64 | social_media_rare_community_engagement_flag int64 | clinical_trial_participation_flag int64 | natural_history_study_enrollment_flag int64 | patient_registry_enrollment_flag int64 | distance_to_specialty_center_miles float64 | travel_burden_days_per_year int64 | telehealth_use_flag int64 | language_barrier_interpretation_needed_flag int64 | immigration_status_concern_flag int64 | food_insecurity_flag int64 | housing_instability_flag int64 | transportation_barrier_flag int64 | missed_appointments_annual_count int64 | sdoh_composite_risk_score float64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCG5-0000200 | Male | Black_non_Hispanic | Latin_America | Urban | Middle | Spanish | TRICARE | Achondroplasia | SKEL | 15 | 100,800 | AD | 3.11 | 0.04 | 0.079 | 1.325 | 1.246 | 1 | 3 | 20 | 1 | 0 | 0 | 0 | null | Single_gene | 18.94 | 0 | 800 | 0 | Metabolic_specialist | 24,789.88 | 5.43 | Delayed | 105.4 | 120 | 97.8 | 86.8 | 71.4 | 1 | 0 | 1 | 3.3 | 0 | 0 | null | 1 | 125 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -0.64 | 1.03 | 0 | 0 | 0 | 0 | 72.69 | 6.483 | 6.65 | 2.63 | 5.82 | 23.5 | 3.11 | 0.078 | 530.3 | 453.5 | 43.7 | 50.1 | 1,185.9 | 0 | Small_molecule | null | null | null | Supportive_metabolic | 2.48 | 27.38 | 199,064 | Denied | 0 | 0 | 13.74 | 1 | 2,077 | Intermediate | 0.355 | 0.616 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 3 | 16 | 1 | 1 | 0 | Ambulatory | Verbal | 1 | 0 | Mainstream_with_support | 1 | 0 | 1 | 15.78 | Respiratory_failure | 1 | 40.1 | 10.9 | 14.6 | 1 | 26,583 | 4.9 | 3,876 | 69.2 | 58.2 | 65.4 | 45.9 | 64.5 | 37.1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 126.2 | 15 | 1 | 0 | 0 | 0 | 0 | 0 | 5 | 0.35 |
HCG5-0000201 | Male | Black_non_Hispanic | Sub_Saharan_Africa | Rural | Middle | Other | Medicaid | 22q11_2_DiGeorge | SYN | 567 | 188,400 | AD | 4.85 | 0.08 | 0.209 | 4.704 | 4.495 | 7 | 11 | 13 | 2 | 0 | 0 | 0 | null | WES | 2.7 | 0 | 4,500 | 1 | NBS_followup | 56,647.75 | 6.12 | Delayed | 66.9 | 68.9 | 74.5 | 67.3 | 104.5 | 0 | 1 | 0 | 1.47 | 1 | 1 | Moderate | 0 | 113.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.19 | 0.97 | 0 | 0 | 0 | 0 | 280.57 | 11.779 | 29.232 | 2.53 | 7.84 | 45 | 3.01 | 0.098 | 686.7 | 575.1 | 57.7 | 3,604.4 | 1,733.4 | 0 | Supportive_only | null | null | null | null | null | 20.45 | 0 | Fully_covered | 0 | 0 | 5.76 | 0 | 1,220 | Low_value | 0.482 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 2 | 32 | 1 | 0 | 0 | Assisted | Limited_verbal | 0 | 0 | Mainstream | 1 | 5 | 1 | 18 | Respiratory_failure | 1 | 24.3 | 17 | 17.8 | 1 | 20,359 | 3.3 | 3,031 | 57.9 | 53.4 | 57.5 | 49.3 | 52.8 | 57.4 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 63.4 | 13 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1.15 |
HCG5-0000202 | Male | Hispanic | North_America | Rural | Middle | Other | Commercial | MERRF | MITO | 551 | 545,000 | MT | 7.76 | 0.22 | 10.235 | 18 | 8.925 | 3 | 9 | 21 | 4 | 0 | 0 | 0 | null | Karyotype | 4.76 | 0 | 1,200 | 1 | Geneticist | 7,809.24 | 8.09 | Regression | 55.2 | 35.7 | 57.3 | 76.3 | 46.6 | 0 | 1 | 0 | 3 | 1 | 0 | null | 1 | 60.4 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | -0.5 | 0.02 | 0 | 0 | 0 | 0 | 370.77 | 48.352 | 10.012 | 3.81 | 1.11 | 27.4 | 1.68 | 0.233 | 169.7 | 147.2 | 17.4 | 36.5 | 1,475 | 0 | Supportive_only | null | null | null | null | null | 7.44 | 0 | Fully_covered | 0 | 0 | 10.37 | 0 | 316 | Intermediate | 0.329 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 1 | 12 | 0 | 1 | 1 | Wheelchair | AAC_device | 1 | 0 | Home_school_medical | 0 | 0 | 1 | 18 | Cardiac | 1 | 66.4 | 14.4 | 17.2 | 0 | 0 | 5.2 | 6,737 | 65.7 | 47.1 | 51.5 | 42.3 | 26.2 | 30.9 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 507.9 | 15 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 0.57 |
HCG5-0000203 | Female | Hispanic | Europe | Urban | High | Spanish | Commercial | Pompe_infantile | LSD | 365 | 232,300 | AR | 7.6 | 0.85 | 0.028 | 0.028 | 0 | 0 | 2 | 8 | 1 | 0 | 1 | 1 | 10.1 | Metabolic | 0.72 | 0 | 900 | 1 | NBS_followup | 6,783.77 | 7.02 | Regression | 46.9 | 42.4 | 53.8 | 54.1 | 93.5 | 0 | 0 | 0 | 3.39 | 8 | 1 | Moderate | 0 | 98.6 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | -1.77 | -0.93 | 0 | 0 | 0 | 0 | 132.22 | 14.4 | 6.216 | 4.36 | 2.25 | 20 | 1.9 | 0.148 | 50.6 | 156.1 | 61.4 | 1,764.5 | 21,392.5 | 1 | ERT | Avalglucosidase_alfa | null | null | null | 2.01 | 2.09 | 582,504 | Denied | 1 | 1 | 7.08 | 1 | 2,279 | Intermediate | 0.253 | 0.747 | 0 | 0 | Non_responder | 0 | null | 0 | 0 | Slow_progression | 7 | 19 | 2 | 0 | 0 | Wheelchair | AAC_device | 1 | 0 | Special_ed | 1 | 5 | 1 | 6.85 | Cardiac | 1 | 25.4 | 15.5 | 9.3 | 1 | 21,553 | 5.2 | 4,435 | 58.9 | 10.2 | 54.4 | 61.2 | 54.3 | 52.7 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 4.1 | 18 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 2.65 |
HCG5-0000204 | Male | White_non_Hispanic | Europe | Urban | Middle | Other | Medicaid | Gaucher_type1 | LSD | 355 | 230,800 | AR | 6.07 | 0.05 | 1.572 | 5.179 | 3.607 | 3 | 11 | 5 | 3 | 1 | 0 | 0 | null | Karyotype | 24.21 | 0 | 1,200 | 0 | Neurologist | 52,840.86 | 3.83 | Regression | 58.3 | 71.3 | 77.7 | 75.3 | 70.4 | 1 | 0 | 0 | 2.33 | 8 | 0 | null | 1 | 65.4 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0.02 | -1.03 | 0 | 0 | 1 | 0 | 327.41 | 17.115 | 6.904 | 8.99 | 4.48 | 200.5 | 1.29 | 0.218 | 175 | 158.7 | 53.8 | 239.4 | 780.6 | 1 | ERT | Velaglucerase | null | null | null | 5.36 | 2.67 | 158,791 | Prior_auth_required | 0 | 0 | 26.79 | 0 | 291 | Intermediate | 0.325 | 0.77 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 5 | 47 | 2 | 1 | 0 | Wheelchair | AAC_device | 0 | 1 | Home_school_medical | 1 | 4 | 0 | null | null | 0 | 59.3 | 18.1 | 13.5 | 0 | 0 | 4.5 | 2,211 | 66.1 | 78.7 | 64.3 | 88.4 | 52.5 | 45.2 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 2.8 | 10 | 1 | 1 | 0 | 1 | 0 | 0 | 5 | 3.08 |
HCG5-0000205 | Female | White_non_Hispanic | Sub_Saharan_Africa | Suburban | Middle | English | Medicaid | MPS_III_Sanfilippo | LSD | 581 | 252,900 | AR | 8.43 | 0.7 | 3.047 | 6.372 | 3.325 | 3 | 9 | 15 | 8 | 0 | 0 | 0 | null | WES | 16.54 | 0 | 4,500 | 1 | Geneticist | 18,923.69 | 7.21 | Profound_delay | 48.2 | 56.9 | 68.3 | 54.8 | 47.6 | 1 | 0 | 0 | 0.8 | 2 | 0 | null | 1 | 53 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | -3.28 | -2.12 | 0 | 0 | 0 | 1 | 183.57 | 29.079 | 4.054 | 4.85 | 3.2 | 64.3 | 1.9 | 0.193 | 101.4 | 294.7 | 59.9 | 200.1 | 4,152.4 | 0 | Supportive_only | null | null | null | null | null | 13.13 | 0 | Prior_auth_required | 0 | 0 | 10.9 | 0 | 387 | Intermediate | 0.489 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 14 | 20 | 0 | 0 | 1 | Bedbound | Nonverbal | 1 | 1 | Mainstream_with_support | 1 | 1 | 1 | 12.53 | Cardiac | 1 | 43.2 | 16.5 | 8.8 | 1 | 156,624 | 6.3 | 10,226 | 39.7 | 52.9 | 51.3 | 21.6 | 32.4 | 50.5 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 41.5 | 4 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | 4.81 |
HCG5-0000206 | Female | Black_non_Hispanic | North_America | Suburban | High | English | Medicaid | Pompe_infantile | LSD | 365 | 232,300 | AR | 8.48 | 0.85 | 0.017 | 0.017 | 0 | 0 | 4 | 6 | 1 | 0 | 1 | 1 | 6.1 | Karyotype | 1.88 | 0 | 1,200 | 1 | NBS_followup | 24,792.04 | 6 | Profound_delay | 75.5 | 51.4 | 34.6 | 64.3 | 10.8 | 1 | 0 | 1 | 1.08 | 2 | 1 | Moderate | 1 | 71.6 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | -1.88 | -0.11 | 0 | 0 | 1 | 0 | 47.74 | 12.14 | 2.089 | 2.48 | 1.1 | 20 | 4.13 | 0.183 | 230.4 | 169.1 | 49.1 | 467.9 | 330.5 | 1 | ASO | null | null | Custom_ASO | null | 0.47 | 4.74 | 863,142 | Partial_coverage | 0 | 0 | 9.65 | 0 | 15,103 | Intermediate | 0.584 | 0.76 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 7 | 4 | 1 | 0 | 1 | Bedbound | Nonverbal | 1 | 0 | Home_school_medical | 1 | 6 | 0 | null | null | 0 | 36 | 9.9 | 5.4 | 1 | 100,651 | 5 | 19,410 | 38.7 | 26.6 | 17.3 | 71.8 | 100 | 19.5 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 222.3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.72 |
HCG5-0000207 | Female | White_non_Hispanic | Europe | Urban | Low | English | Commercial | MLD | LD | 512 | 250,100 | AR | 9.82 | 0.7 | 0.013 | 0.013 | 0 | 0 | 3 | 18 | 1 | 0 | 1 | 1 | 4.7 | Panel | 1.07 | 1 | 1,500 | 0 | NBS_followup | 14,856.99 | 4.15 | Profound_delay | 52.7 | 23 | 48.5 | 19.3 | 89.7 | 1 | 0 | 1 | 1.03 | 4 | 0 | null | 0 | 84.6 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -3.03 | -1.38 | 0 | 0 | 0 | 0 | 264.68 | 3.687 | 2.647 | 25.79 | 6.58 | 20 | 3.69 | 0.113 | 135.2 | 678.7 | 57.6 | 87.2 | 693.7 | 1 | HSCT | null | null | null | null | 0.44 | 5.37 | 311,147 | Partial_coverage | 0 | 0 | 9.34 | 1 | 8,450 | Intermediate | 0.191 | 0.42 | 0 | 0 | Responder | 1 | Cord | 0 | 1 | Slow_progression | 3 | 8 | 3 | 1 | 0 | Bedbound | Nonverbal | 1 | 1 | Home_school_medical | 1 | 3 | 0 | null | null | 0 | 36.5 | 24.2 | 10.3 | 0 | 0 | 4.7 | 11,492 | 43.8 | 20.6 | 51.4 | 68 | 14.3 | 61 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 46 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HCG5-0000208 | Male | White_non_Hispanic | Latin_America | Urban | Low | English | Medicaid_CHIP | Pompe_infantile | LSD | 365 | 232,300 | AR | 8.04 | 0.85 | 0.003 | 0.003 | 0 | 0 | 4 | 15 | 3 | 0 | 1 | 1 | 1.2 | MLPA | 0.5 | 0 | 1,000 | 1 | NBS_followup | 61,177.17 | 6.07 | Profound_delay | 62.6 | 71.2 | 16.5 | 51.5 | 53.3 | 0 | 0 | 0 | 5.77 | 5 | 1 | Mild | 1 | 32.7 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | -0.31 | -1.1 | 0 | 0 | 1 | 0 | 134.22 | 11.344 | 12.694 | 3.62 | 8.76 | 20 | 3.11 | 0.17 | 32.7 | 330.4 | 33.4 | 580.3 | 1,327.2 | 1 | ERT | Alglucosidase_alfa | null | null | null | 1.58 | 9.2 | 843,076 | Fully_covered | 0 | 0 | 36 | 1 | 1,449 | Intermediate | 0.386 | 0.648 | 0 | 1 | Partial | 0 | null | 0 | 0 | Stable | 4 | 27 | 1 | 0 | 0 | Bedbound | Nonverbal | 0 | 1 | Home_school_medical | 0 | 2 | 1 | 14.57 | Cardiac | 1 | 49.1 | 2 | 15.1 | 1 | 108,374 | 4.7 | 7,173 | 61.1 | 58.2 | 37.5 | 57.6 | 55.9 | 90.8 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 34.4 | 7 | 1 | 0 | 0 | 0 | 0 | 0 | 13 | 0 |
HCG5-0000209 | Male | White_non_Hispanic | North_America | Urban | Middle | English | Commercial | MERRF | MITO | 551 | 545,000 | MT | 9.24 | 0.22 | 11.899 | 13.982 | 2.083 | 1 | 12 | 9 | 0 | 0 | 0 | 0 | null | WES | 48.82 | 0 | 4,500 | 1 | Geneticist | 35,217.37 | 8.18 | Profound_delay | 31.8 | 79.5 | 10 | 37.2 | 10 | 1 | 1 | 0 | 1.07 | 3 | 0 | null | 0 | 98.6 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | -1.3 | 0.6 | 0 | 0 | 0 | 0 | 13.27 | 19.913 | 22.297 | 2.17 | 2.57 | 20 | 3.96 | 0.183 | 1,119.2 | 496.5 | 61 | 629 | 1,586.1 | 0 | Supportive_only | null | null | null | null | null | 6.34 | 0 | Partial_coverage | 0 | 0 | 6.43 | 0 | 196 | Intermediate | 0.41 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Moderate | 5 | 18 | 2 | 1 | 0 | Bedbound | Nonverbal | 1 | 1 | Mainstream | 1 | 6 | 0 | null | null | 0 | 44.3 | 19.2 | 10 | 0 | 0 | 4.1 | 5,555 | 53.8 | 42.5 | 74.8 | 45.5 | 54.8 | 45.8 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 6.8 | 10 | 1 | 0 | 0 | 1 | 0 | 0 | 3 | 0.66 |
HCG5-0000210 | Female | Hispanic | Asia_Pacific | Rural | High | English | Commercial | X_ALD | LD | 43 | 300,100 | XLR | 7.29 | 0.55 | 0.015 | 0.015 | 0 | 0 | 2 | 9 | 2 | 0 | 1 | 1 | 5.3 | Panel | 0.55 | 0 | 1,500 | 1 | NBS_followup | 33,409.57 | 7.7 | Regression | 36.5 | 55.4 | 87.3 | 65 | 79.5 | 1 | 0 | 0 | 4.18 | 8 | 1 | Moderate | 0 | 101.5 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | -0.38 | 2.3 | 0 | 0 | 0 | 0 | 122.64 | 33.839 | 117.571 | 0.99 | 6.79 | 158.6 | 1.79 | 0.399 | 206.7 | 285.4 | 99.6 | 247.9 | 1,374.1 | 1 | ASO | null | null | Custom_ASO | null | 0.07 | 1.46 | 193,120 | Fully_covered | 0 | 0 | 7.75 | 1 | 2,004 | Intermediate | 0.17 | 0.778 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 2 | 26 | 0 | 0 | 0 | Wheelchair | AAC_device | 1 | 0 | Mainstream_with_support | 1 | 3 | 0 | null | null | 0 | 47.9 | 15.8 | 18.1 | 0 | 0 | 5.1 | 10,781 | 65.8 | 50.4 | 65.5 | 69.2 | 40.3 | 27.8 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 39 | 15 | 1 | 1 | 0 | 0 | 0 | 0 | 4 | 0.73 |
HCG5-0000211 | Female | Hispanic | North_America | Urban | Low | Spanish | Commercial | SMA_type2 | NM | 83,418 | 253,550 | AR | 7.18 | 0.25 | 0.016 | 0.016 | 0 | 0 | 4 | 7 | 1 | 0 | 1 | 1 | 5.7 | WES | 1.68 | 1 | 4,500 | 1 | NBS_followup | 9,389.45 | 6.4 | Regression | 60.3 | 89.9 | 42.7 | 58.2 | 57.3 | 0 | 0 | 0 | 3.38 | 2 | 1 | Severe | 1 | 51.8 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | -3.48 | 0.2 | 1 | 1 | 0 | 0 | 33.33 | 18.435 | 11.737 | 4.82 | 20.62 | 136.7 | 1.1 | 0.144 | 164.7 | 551.4 | 31.6 | 322.2 | 1,637 | 1 | Supportive_only | null | null | null | null | null | 2.31 | 0 | Fully_covered | 0 | 0 | 7.35 | 0 | 104 | High_value | 0.501 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 10 | 14 | 0 | 1 | 1 | Wheelchair | AAC_device | 1 | 0 | Not_enrolled | 1 | 1 | 0 | null | null | 0 | 19.9 | 20.6 | 11.2 | 0 | 0 | 5.1 | 3,462 | 36.9 | 54.5 | 76.4 | 55.3 | 52.4 | 63.5 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 30.5 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 3 | 4.41 |
HCG5-0000212 | Male | Black_non_Hispanic | MENA | Rural | Low | Mandarin | Other_public | MPS_II_Hunter | LSD | 580 | 309,900 | XLR | 9.85 | 0.72 | 0.854 | 5.199 | 4.344 | 6 | 14 | 12 | 0 | 0 | 0 | 0 | null | WGS | 9.85 | 0 | 8,500 | 1 | Geneticist | 42,249.8 | 7.78 | Profound_delay | 58.4 | 55.4 | 36.3 | 24.3 | 22.4 | 0 | 0 | 0 | 5.92 | 5 | 1 | Moderate | 1 | 61.8 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | -2.52 | -0.57 | 0 | 0 | 1 | 1 | 52.9 | 33.336 | 3.85 | 7.79 | 13.1 | 20 | 2.03 | 0.222 | 65 | 136.7 | 32.4 | 2,043.9 | 907.8 | 1 | ERT | Idursulfase | null | null | null | 5.74 | 2.37 | 104,514 | Fully_covered | 0 | 0 | 1.14 | 0 | 2,048 | High_value | 0.401 | 0.56 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 0 | 19 | 1 | 0 | 0 | Bedbound | Nonverbal | 1 | 1 | Special_ed | 1 | 6 | 0 | null | null | 0 | 21 | 12.6 | 6.1 | 1 | 8,132 | 5.5 | 13,925 | 21.4 | 40 | 41.9 | 45.1 | 50.1 | 39 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 45.3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HCG5-0000213 | Male | White_non_Hispanic | Latin_America | Urban | Low | English | Commercial | SCID | IMM | 183 | 300,400 | XLR | 9.21 | 0.92 | 0.021 | 0.021 | 0 | 0 | 2 | 9 | 0 | 0 | 1 | 1 | 7.8 | Panel | 1.94 | 0 | 1,500 | 1 | NBS_followup | 11,014.95 | 5 | Profound_delay | 71.1 | 85 | 10 | 33.7 | 67.1 | 1 | 1 | 1 | 4.54 | 2 | 0 | null | 0 | 109.1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | -3.94 | -0.43 | 0 | 1 | 0 | 0 | 141.32 | 51.021 | 11.874 | 1.8 | 2.67 | 247.8 | 2.12 | 0.157 | 138.3 | 356.2 | 69.5 | 500.8 | 6,552.3 | 1 | Supportive_only | null | null | null | null | null | 4.48 | 0 | Prior_auth_required | 0 | 0 | 7.27 | 0 | 456 | Cost_saving | 0.251 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 2 | 7 | 4 | 0 | 0 | Bedbound | Nonverbal | 1 | 1 | Special_ed | 1 | 0 | 1 | 0.91 | Respiratory_failure | 0 | 23.9 | 10.8 | 9.9 | 1 | 12,599 | 6.3 | 1,667 | 38.4 | 0 | 70.5 | 13.5 | 40.3 | 52.9 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 46.7 | 13 | 1 | 0 | 0 | 1 | 1 | 0 | 3 | 3.66 |
HCG5-0000214 | Female | White_non_Hispanic | North_America | Rural | High | English | Commercial | Canavan | LD | 141 | 271,900 | AR | 10 | 0.82 | 0.1 | 3.627 | 3.527 | 0 | 14 | 13 | 3 | 1 | 0 | 0 | null | Single_gene | 6.02 | 0 | 800 | 0 | Immunologist | 14,872.99 | 4.17 | Profound_delay | 10 | 47 | 10 | 66.3 | 10 | 0 | 0 | 1 | 3.06 | 6 | 0 | null | 0 | 86.9 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | -1.37 | 1.42 | 1 | 0 | 0 | 0 | 168.14 | 60.856 | 22.934 | 7.39 | 1.23 | 86.8 | 3.34 | 0.125 | 86.8 | 468.9 | 30.3 | 103.5 | 664.9 | 0 | Supportive_only | null | null | null | null | null | 11.01 | 0 | Fully_covered | 0 | 0 | 16.69 | 0 | 433 | Intermediate | 0.333 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 6 | 40 | 4 | 0 | 0 | Bedbound | Nonverbal | 1 | 0 | Mainstream_with_support | 1 | 4 | 1 | 7.89 | Metabolic_crisis | 1 | 61.2 | 7.4 | 8.3 | 1 | 33,788 | 7.6 | 1,049 | 33.3 | 26.8 | 30.7 | 57.2 | 27.6 | 41.6 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 116.8 | 31 | 1 | 0 | 0 | 0 | 1 | 0 | 6 | 2.67 |
HCG5-0000215 | Male | Black_non_Hispanic | Asia_Pacific | Urban | Low | Spanish | Commercial | OI_type1_to_4 | SKEL | 666 | 166,200 | AD | 3.16 | 0.06 | 0.714 | 6.838 | 6.124 | 1 | 14 | 6 | 3 | 1 | 0 | 0 | null | WGS | 31.58 | 0 | 8,500 | 1 | Neurologist | 7,872.94 | 8.12 | Delayed | 123.5 | 83 | 62.9 | 47.3 | 66 | 0 | 0 | 0 | 3.87 | 6 | 0 | null | 0 | 78.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -2.31 | 0.22 | 0 | 0 | 0 | 0 | 78.65 | 25.922 | 30.789 | 4.79 | 4.08 | 48.6 | 3.02 | 0.234 | 58.4 | 489.1 | 27 | 558.7 | 3,806.5 | 1 | Supportive_only | null | null | null | null | null | 10.53 | 0 | Partial_coverage | 0 | 0 | 10.63 | 0 | 664 | Intermediate | 0.516 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 2 | 7 | 3 | 1 | 0 | Ambulatory | Verbal | 0 | 0 | Special_ed | 1 | 2 | 1 | 15.04 | Respiratory_failure | 1 | 64.8 | 5.6 | 16.4 | 1 | 25,339 | 7 | 11,088 | 45.2 | 66.7 | 65.3 | 91 | 55.3 | 24.7 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 33.8 | 13 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 10 |
HCG5-0000216 | Female | White_non_Hispanic | North_America | Urban | Middle | English | Commercial | Pompe_infantile | LSD | 365 | 232,300 | AR | 8.47 | 0.85 | 0.026 | 0.026 | 0 | 0 | 4 | 7 | 2 | 0 | 1 | 1 | 9.4 | Metabolic | 4.37 | 0 | 900 | 0 | NBS_followup | 23,367.76 | 3.27 | Profound_delay | 52.5 | 63.5 | 54.2 | 58.4 | 44.3 | 0 | 0 | 0 | 1.03 | 0 | 1 | Severe | 1 | 39.4 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | -0.89 | -0.09 | 1 | 0 | 1 | 0 | 307.14 | 7.977 | 28.214 | 1.08 | 27.45 | 122.3 | 4.08 | 0.352 | 297.5 | 311.4 | 60.1 | 135.4 | 3,560.4 | 1 | ERT | Alglucosidase_alfa | null | null | null | 2.16 | 36.79 | 117,236 | Partial_coverage | 0 | 0 | 26.05 | 0 | 5,719 | Low_value | 0.596 | 0.695 | 0 | 0 | Partial | 0 | null | 0 | 0 | Slow_progression | 0 | 22 | 5 | 0 | 1 | Bedbound | Nonverbal | 1 | 1 | Mainstream_with_support | 0 | 5 | 1 | 1.2 | Cardiac | 0 | 45.1 | 12.5 | 13.6 | 1 | 28,069 | 3.9 | 2,052 | 45.1 | 52.5 | 37.7 | 23.4 | 30.4 | 56.7 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 21.4 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HCG5-0000217 | Male | Black_non_Hispanic | Europe | Rural | High | English | Commercial | Pompe_infantile | LSD | 365 | 232,300 | AR | 9.48 | 0.85 | 0.02 | 0.02 | 0 | 0 | 2 | 6 | 5 | 0 | 1 | 1 | 7.3 | WES | 2.97 | 0 | 4,500 | 1 | NBS_followup | 70,124.39 | 6.76 | Profound_delay | 54.8 | 33 | 22.8 | 62 | 63.8 | 0 | 1 | 1 | 2.93 | 3 | 1 | Mild | 1 | 49.4 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | -1.76 | 0.02 | 0 | 0 | 0 | 0 | 161.66 | 7.239 | 20.399 | 7.39 | 11.07 | 87 | 0.66 | 0.184 | 139.4 | 155.2 | 33.1 | 109.4 | 700.8 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 0.63 | 2.12 | 17,004 | Fully_covered | 0 | 0 | 13.56 | 1 | 630 | Intermediate | 0.481 | 0.924 | 0 | 0 | Responder | 0 | null | 0 | 0 | Slow_progression | 6 | 44 | 3 | 1 | 0 | Bedbound | Nonverbal | 1 | 1 | Home_school_medical | 1 | 1 | 1 | 10.72 | Neurodegeneration | 1 | 60 | 8.8 | 11.1 | 0 | 0 | 6.9 | 2,820 | 23.3 | 27.1 | 64.3 | 31.4 | 71.4 | 41.5 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 55.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1.19 |
HCG5-0000218 | Female | Hispanic | Europe | Rural | Low | English | Uninsured | CDKL5_encephalopathy | SYN | 3,095 | 300,672 | XLD | 9.8 | 0.22 | 0.603 | 5.424 | 4.821 | 0 | 15 | 15 | 2 | 0 | 0 | 0 | null | Single_gene | 12.91 | 0 | 800 | 1 | Geneticist | 32,992.17 | 8.64 | Profound_delay | 10 | 47 | 24.4 | 47.3 | 92.5 | 0 | 0 | 1 | 1.12 | 1 | 0 | null | 0 | 121.8 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | -4.36 | -2.69 | 0 | 0 | 0 | 0 | 118.63 | 7.872 | 13.273 | 3.63 | 3.3 | 45.4 | 1.38 | 0.126 | 600.8 | 605.3 | 105.1 | 430.1 | 1,252.6 | 0 | Supportive_only | null | null | null | null | null | 13.97 | 0 | Fully_covered | 0 | 0 | 10.5 | 0 | 3,093 | Cost_saving | 0.763 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Moderate | 12 | 6 | 0 | 0 | 0 | Bedbound | Nonverbal | 1 | 0 | Mainstream | 1 | 4 | 0 | null | null | 0 | 54.7 | 9.7 | 15.2 | 1 | 152,947 | 7.1 | 2,126 | 35.5 | 34.9 | 85.1 | 39 | 59.7 | 27.3 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 53.5 | 12 | 0 | 0 | 0 | 0 | 1 | 0 | 3 | 1.47 |
HCG5-0000219 | Female | White_non_Hispanic | Asia_Pacific | Urban | Middle | English | Medicaid_CHIP | OTC | UCD | 664 | 311,250 | XLR | 8.92 | 0.52 | 0.178 | 1.349 | 1.17 | 2 | 8 | 9 | 1 | 0 | 0 | 0 | null | WES | 7.13 | 0 | 4,500 | 1 | Cardiologist | 18,076.38 | 4.83 | Profound_delay | 37.7 | 70 | 21.9 | 79.4 | 42.9 | 0 | 0 | 1 | 4.06 | 1 | 0 | null | 1 | 50.6 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | -3.79 | 0.22 | 1 | 0 | 1 | 0 | 189.31 | 8.437 | 23.644 | 1.82 | 13.55 | 26.2 | 2.11 | 0.199 | 158.8 | 300 | 32.3 | 80.6 | 1,803.6 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 1.76 | 4.2 | 950,862 | Fully_covered | 0 | 0 | 14.88 | 1 | 13,034 | High_value | 0.621 | 0.794 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 6 | 29 | 2 | 0 | 1 | Bedbound | Nonverbal | 0 | 1 | Special_ed | 1 | 3 | 1 | 12.31 | Other | 1 | 65.5 | 7.3 | 7.4 | 1 | 23,050 | 6.7 | 10,900 | 30.3 | 61.5 | 60.8 | 44.8 | 44.3 | 56.8 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 14.2 | 12 | 1 | 0 | 0 | 0 | 0 | 1 | 3 | 1.04 |
HCG5-0000220 | Female | White_non_Hispanic | North_America | Urban | Middle | English | Commercial | MMA | OA | 27 | 251,000 | AR | 8.31 | 0.45 | 0.013 | 0.013 | 0 | 0 | 4 | 17 | 0 | 1 | 1 | 1 | 4.7 | Single_gene | 12 | 1 | 800 | 1 | NBS_followup | 29,680.09 | 4.7 | Profound_delay | 60.8 | 64 | 66.3 | 63.8 | 61.9 | 1 | 0 | 0 | 1.15 | 2 | 0 | null | 0 | 95.9 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | -1.7 | -1.8 | 1 | 1 | 0 | 0 | 604.9 | 24.275 | 4.194 | 9.64 | 9.51 | 31.5 | 2.97 | 0.185 | 280.8 | 313.3 | 25.2 | 257.5 | 9,656.8 | 0 | Supportive_only | null | null | null | null | null | 72 | 0 | Fully_covered | 0 | 0 | 9.28 | 0 | 17,600 | Cost_saving | 0.519 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 1 | 32 | 2 | 1 | 0 | Bedbound | Nonverbal | 1 | 0 | Home_school_medical | 1 | 3 | 0 | null | null | 0 | 65.5 | 19.7 | 5.4 | 0 | 0 | 5.3 | 2,704 | 28.2 | 68.2 | 26.9 | 37.3 | 27.8 | 97.6 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 82.4 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0.73 |
HCG5-0000221 | Male | White_non_Hispanic | North_America | Urban | High | Mandarin | Commercial | MELAS | MITO | 550 | 540,000 | MT | 8.27 | 0.28 | 2.091 | 5.061 | 2.97 | 0 | 11 | 17 | 1 | 0 | 0 | 0 | null | Panel | 4.09 | 0 | 1,500 | 1 | Geneticist | 29,532.68 | 6.85 | Profound_delay | 25.1 | 48.1 | 60.3 | 53.5 | 112.5 | 0 | 0 | 0 | 2.83 | 0 | 1 | Moderate | 1 | 47.9 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | -1.24 | 0.23 | 0 | 0 | 1 | 0 | 21.11 | 121.352 | 1.999 | 9.49 | 0.6 | 20 | 7.82 | 0.401 | 271.4 | 1,107.2 | 44.6 | 513.4 | 1,249.9 | 0 | Small_molecule | null | null | null | Supportive_metabolic | 5.41 | 8.88 | 125,332 | Prior_auth_required | 0 | 0 | 5.19 | 1 | 4,084 | Cost_saving | 0.294 | 0.743 | 0 | 0 | Non_responder | 0 | null | 0 | 0 | Moderate | 1 | 47 | 1 | 0 | 1 | Bedbound | Nonverbal | 1 | 0 | Home_school_medical | 1 | 4 | 0 | null | null | 0 | 31.3 | 9.1 | 4.8 | 1 | 33,212 | 7.6 | 24,103 | 27.2 | 46.8 | 42.6 | 77.1 | 37.3 | 67.9 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 13.6 | 37 | 0 | 1 | 0 | 0 | 0 | 1 | 3 | 5.2 |
HCG5-0000222 | Male | Asian | Asia_Pacific | Urban | Middle | Spanish | Commercial | Myotonic_congenital | NM | 590 | 160,900 | AD | 6.07 | 0.1 | 2.017 | 3.978 | 1.961 | 2 | 7 | 13 | 1 | 1 | 0 | 0 | null | Single_gene | 26.61 | 0 | 800 | 1 | Other | 28,551.42 | 7.39 | Regression | 10 | 66.2 | 47.3 | 51.7 | 64.9 | 0 | 0 | 0 | 1.94 | 1 | 1 | Mild | 0 | 79 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.46 | -1.58 | 0 | 0 | 0 | 0 | 664.83 | 26.862 | 80.152 | 1.79 | 8.63 | 20 | 1.24 | 0.222 | 388.3 | 383.1 | 60.6 | 1,999.6 | 50,000 | 0 | Supportive_only | null | null | null | null | null | 5.38 | 0 | Partial_coverage | 0 | 0 | 5.96 | 0 | 6,363 | Intermediate | 0.624 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 2 | 6 | 0 | 1 | 0 | Wheelchair | AAC_device | 0 | 0 | Home_school_medical | 1 | 2 | 0 | null | null | 0 | 49.6 | 15.2 | 1.4 | 0 | 0 | 4.7 | 12,940 | 37.2 | 64.6 | 100 | 96.5 | 36.8 | 49.2 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 111.9 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
HCG5-0000223 | Female | Black_non_Hispanic | Europe | Urban | Middle | Spanish | Medicaid_CHIP | Williams | SYN | 904 | 194,050 | AD | 1.93 | 0.04 | 0.117 | 2.375 | 2.258 | 0 | 11 | 13 | 7 | 0 | 0 | 0 | null | WES | 15.38 | 0 | 4,500 | 1 | NBS_followup | 31,558.59 | 4.39 | On_track | 93.5 | 102.4 | 100.9 | 95.1 | 99.1 | 0 | 1 | 0 | 1.81 | 1 | 1 | Mild | 1 | 35.7 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | -1.9 | 0.55 | 0 | 0 | 0 | 0 | 97.84 | 20.582 | 11.678 | 5.67 | 3.69 | 455 | 1.45 | 0.114 | 89.2 | 281.6 | 55.9 | 493.8 | 3,896.7 | 0 | Supportive_only | null | null | null | null | null | 13.49 | 0 | Partial_coverage | 0 | 0 | 0.78 | 0 | 3,175 | Intermediate | 0.282 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Moderate | 3 | 45 | 1 | 0 | 0 | Ambulatory | Verbal | 0 | 0 | Mainstream | 1 | 2 | 0 | null | null | 0 | 55.5 | 10.8 | 4.2 | 0 | 0 | 7.1 | 7,819 | 74.5 | 66.3 | 83.7 | 70.1 | 57.9 | 95.1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 30.6 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 5 | 0.01 |
HCG5-0000224 | Male | White_non_Hispanic | Europe | Rural | Low | English | Commercial | MMA | OA | 27 | 251,000 | AR | 9.23 | 0.45 | 0.015 | 0.015 | 0 | 0 | 4 | 17 | 4 | 1 | 1 | 1 | 5.6 | Panel | 1.04 | 0 | 1,500 | 1 | NBS_followup | 10,551.31 | 3.83 | Profound_delay | 39.1 | 56.5 | 30.2 | 53 | 19.2 | 0 | 0 | 0 | 1.42 | 4 | 0 | null | 1 | 57.2 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | -3.02 | -0.64 | 1 | 1 | 1 | 0 | 83.19 | 52.757 | 19.698 | 5.27 | 1.52 | 20 | 1.73 | 0.275 | 719.8 | 273.3 | 65.2 | 48.6 | 2,549.1 | 0 | Small_molecule | null | null | null | Supportive_metabolic | 1.84 | 12.39 | 671,548 | Fully_covered | 0 | 0 | 28.09 | 1 | 3,521 | Intermediate | 0.554 | 0.602 | 0 | 0 | Responder | 0 | null | 0 | 0 | Moderate | 4 | 39 | 4 | 1 | 0 | Bedbound | Nonverbal | 1 | 1 | Special_ed | 1 | 2 | 0 | null | null | 0 | 61.4 | 15.9 | 14.1 | 0 | 0 | 7 | 29,714 | 41.8 | 51.4 | 38.8 | 36.4 | 6.5 | 24.3 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 15.6 | 8 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 3.87 |
HCG5-0000225 | Male | Asian | North_America | Urban | Middle | Mandarin | Commercial | CDKL5_encephalopathy | SYN | 3,095 | 300,672 | XLD | 7.49 | 0.22 | 0.279 | 2.581 | 2.302 | 2 | 10 | 14 | 1 | 0 | 0 | 0 | null | Single_gene | 13.27 | 0 | 800 | 1 | Other | 29,610.51 | 7.41 | Regression | 77.2 | 67.8 | 40.4 | 51.4 | 99.6 | 0 | 0 | 1 | 5.62 | 4 | 0 | null | 1 | 43.6 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | -3.13 | -2.23 | 0 | 1 | 0 | 0 | 121.25 | 10.531 | 0.979 | 4.24 | 3.6 | 20 | 1.42 | 0.225 | 59.4 | 504 | 30.3 | 57.7 | 4,377.4 | 0 | Supportive_only | null | null | null | null | null | 6.57 | 0 | Partial_coverage | 0 | 0 | 5.59 | 0 | 147 | High_value | 0 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 2 | 14 | 1 | 0 | 1 | Wheelchair | AAC_device | 1 | 0 | Mainstream_with_support | 0 | 1 | 1 | 6.35 | Respiratory_failure | 0 | 58.7 | 11.7 | 14.5 | 1 | 76,564 | 6.4 | 2,358 | 53.3 | 42.3 | 74.5 | 56.7 | 33.9 | 60.2 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1,152.2 | 13 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 1.21 |
HCG5-0000226 | Male | White_non_Hispanic | North_America | Suburban | Middle | Spanish | Uninsured | Gaucher_type1 | LSD | 355 | 230,800 | AR | 5.38 | 0.05 | 0.342 | 5.777 | 5.436 | 3 | 10 | 20 | 0 | 0 | 0 | 0 | null | Panel | 6.62 | 0 | 1,500 | 0 | Other | 5,542.92 | 7.44 | Delayed | 62.2 | 73.1 | 61.3 | 50.9 | 53.1 | 0 | 0 | 0 | 5.42 | 2 | 0 | null | 0 | 116 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | -2.59 | -0.87 | 0 | 0 | 1 | 0 | 74.69 | 56.703 | 48.931 | 2.97 | 4.82 | 129.7 | 1.31 | 0.24 | 257.5 | 242.2 | 99 | 1,634.3 | 324.2 | 1 | ERT | Imiglucerase | null | null | null | 6.27 | 19.17 | 313,009 | Fully_covered | 0 | 0 | 2.61 | 0 | 9,446 | High_value | 0.331 | 0.886 | 1 | 0 | Non_responder | 0 | null | 0 | 0 | Slow_progression | 0 | 9 | 1 | 0 | 0 | Assisted | Limited_verbal | 0 | 0 | Not_enrolled | 0 | 6 | 0 | null | null | 0 | 45.8 | 17.3 | 6 | 1 | 293,108 | 3.6 | 6,837 | 52.9 | 36.8 | 63.6 | 35.7 | 27.3 | 78.6 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 61.3 | 14 | 1 | 0 | 0 | 0 | 0 | 1 | 10 | 2.11 |
HCG5-0000227 | Male | White_non_Hispanic | Latin_America | Urban | Low | English | Medicaid | SMA_type1 | NM | 83,330 | 253,300 | AR | 9.72 | 0.9 | 0.01 | 0.01 | 0 | 0 | 3 | 15 | 8 | 0 | 1 | 1 | 3.5 | WES | 1.69 | 1 | 4,500 | 1 | NBS_followup | 45,164.26 | 4 | Profound_delay | 35.3 | 24.1 | 45.5 | 14 | 49.5 | 0 | 0 | 1 | 3.69 | 1 | 1 | Severe | 1 | 52.6 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | -1.65 | 3.13 | 0 | 0 | 0 | 0 | 64.05 | 53.044 | 34.477 | 3.98 | 1.62 | 51.8 | 2.29 | 0.197 | 57.6 | 471.5 | 14 | 121.8 | 5,836.4 | 1 | Supportive_only | null | null | null | null | null | 52.53 | 0 | Fully_covered | 0 | 0 | 4.81 | 0 | 1,132 | Low_value | 0.168 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 3 | 30 | 0 | 0 | 0 | Bedbound | Nonverbal | 1 | 1 | Special_ed | 1 | 3 | 1 | 5.28 | Infection | 1 | 59.2 | 17.6 | 1.4 | 1 | 148,346 | 6 | 608 | 57.2 | 72.9 | 100 | 44.3 | 25.1 | 36.5 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 174.7 | 6 | 1 | 0 | 0 | 1 | 0 | 0 | 4 | 2.11 |
HCG5-0000228 | Male | Asian | North_America | Urban | Middle | Spanish | Commercial | CMT_1A_1B | NM | 101,081 | 118,220 | AD | 4.06 | 0.02 | 12 | 13.541 | 1.541 | 2 | 7 | 10 | 1 | 1 | 0 | 0 | null | Panel | 15.13 | 0 | 1,500 | 1 | Geneticist | 9,971.89 | 8.12 | Delayed | 86.2 | 62.2 | 52.9 | 77.2 | 81.8 | 0 | 0 | 1 | 4.81 | 1 | 0 | null | 0 | 87 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -2.65 | -4.04 | 0 | 0 | 0 | 0 | 422.77 | 23.408 | 2.977 | 9.5 | 2.98 | 56.1 | 4.02 | 0.247 | 211.7 | 633.1 | 25.9 | 46.1 | 481.6 | 0 | Supportive_only | null | null | null | null | null | 27.38 | 0 | Partial_coverage | 0 | 0 | 32.51 | 0 | 9,881 | Cost_saving | 0.368 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 3 | 14 | 1 | 0 | 0 | Assisted | Limited_verbal | 0 | 0 | Home_school_medical | 1 | 2 | 0 | null | null | 0 | 25.4 | 19.5 | 8 | 0 | 0 | 6.8 | 3,541 | 68.9 | 88.8 | 65.2 | 71.9 | 95 | 53.1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 50.4 | 15 | 1 | 1 | 0 | 0 | 0 | 0 | 10 | 2.05 |
HCG5-0000229 | Male | White_non_Hispanic | North_America | Suburban | High | English | Commercial | Fabry | LSD | 324 | 301,500 | XLR | 3.67 | 0.04 | 6.105 | 8.358 | 2.253 | 4 | 9 | 20 | 10 | 1 | 0 | 0 | null | Single_gene | 120 | 0 | 800 | 1 | Geneticist | 77,640 | 4.47 | Delayed | 94.7 | 86 | 84.8 | 48 | 80.6 | 0 | 0 | 0 | 0.85 | 3 | 0 | null | 0 | 84 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | -4.18 | -0.13 | 0 | 0 | 1 | 0 | 212.66 | 146.112 | 9.156 | 6.22 | 2.47 | 29.4 | 2.39 | 0.197 | 712.7 | 349.3 | 45.9 | 81 | 4,314.2 | 1 | ASO | null | null | Custom_ASO | null | 9.53 | 8.47 | 343,482 | Partial_coverage | 0 | 0 | 7.13 | 0 | 7,603 | High_value | 0.143 | 0.9 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 1 | 48 | 0 | 0 | 0 | Ambulatory | Verbal | 0 | 0 | Mainstream_with_support | 1 | 5 | 0 | null | null | 0 | 25.7 | 8.1 | 12.4 | 1 | 25,447 | 5.9 | 1,608 | 70.4 | 54.5 | 59.8 | 74.9 | 48.6 | 37.9 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 231.3 | 39 | 1 | 0 | 0 | 0 | 0 | 0 | 18 | 0.92 |
HCG5-0000230 | Male | White_non_Hispanic | MENA | Urban | Low | English | Uninsured | Pompe_infantile | LSD | 365 | 232,300 | AR | 6.67 | 0.85 | 0.003 | 0.003 | 0 | 0 | 2 | 7 | 7 | 0 | 1 | 1 | 1 | WES | 3.22 | 1 | 4,500 | 1 | NBS_followup | 2,978.83 | 6.95 | Regression | 43.9 | 74.4 | 105.7 | 47.7 | 51.7 | 0 | 0 | 0 | 2.9 | 5 | 1 | Mild | 1 | 63.2 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | -1.66 | -2.02 | 1 | 0 | 1 | 0 | 26.64 | 60.564 | 15.481 | 0.96 | 6.79 | 131 | 1.33 | 0.149 | 476.6 | 598.2 | 27.4 | 586.1 | 999.7 | 1 | ERT | Avalglucosidase_alfa | null | null | null | 0.21 | 70.41 | 447,246 | Fully_covered | 0 | 0 | 8.43 | 1 | 11,827 | Cost_saving | 0.425 | 0.519 | 0 | 0 | Non_responder | 0 | null | 0 | 0 | Rapid | 6 | 60 | 0 | 0 | 1 | Wheelchair | AAC_device | 1 | 0 | Home_school_medical | 1 | 0 | 1 | 16.95 | Other | 0 | 68.5 | 7.9 | 14.8 | 1 | 17,202 | 5.7 | 14,913 | 50 | 52.9 | 57.3 | 66.4 | 52.5 | 44.9 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 122.8 | 15 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2.38 |
HCG5-0000231 | Male | Black_non_Hispanic | North_America | Suburban | Low | English | TRICARE | CPS1 | UCD | 147 | 237,300 | AR | 7.3 | 0.62 | 0.161 | 0.637 | 0.476 | 2 | 5 | 26 | 1 | 1 | 0 | 0 | null | WGS | 18.47 | 0 | 8,500 | 1 | Other | 121,416.55 | 4.66 | Regression | 69.6 | 68.1 | 52.8 | 10 | 63 | 0 | 0 | 0 | 1.75 | 0 | 0 | null | 0 | 120.8 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | -2.22 | 1.8 | 1 | 0 | 0 | 1 | 355.71 | 23.124 | 3.906 | 0.81 | 2.53 | 311.5 | 1.98 | 0.174 | 871.5 | 352.7 | 36 | 277 | 813 | 1 | Supportive_only | null | null | null | null | null | 16.95 | 0 | Fully_covered | 0 | 0 | 36 | 0 | 360 | Intermediate | 0.504 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 3 | 12 | 2 | 1 | 0 | Wheelchair | AAC_device | 0 | 0 | Mainstream_with_support | 1 | 5 | 1 | 9.94 | Respiratory_failure | 0 | 63.1 | 10.9 | 12 | 1 | 40,175 | 5.4 | 21,175 | 51.1 | 46.5 | 50 | 44.5 | 41.7 | 57.4 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 40.3 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.19 |
HCG5-0000232 | Male | White_non_Hispanic | Asia_Pacific | Urban | Middle | English | Commercial | 22q11_2_DiGeorge | SYN | 567 | 188,400 | AD | 5.99 | 0.08 | 0.156 | 5.874 | 5.718 | 0 | 10 | 12 | 2 | 1 | 0 | 0 | null | WGS | 19.6 | 0 | 8,500 | 1 | Geneticist | 6,153.04 | 8.11 | Delayed | 51.7 | 50 | 58.8 | 76.9 | 103.9 | 1 | 1 | 0 | 2.85 | 7 | 1 | Moderate | 0 | 65.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.93 | 0.91 | 0 | 0 | 0 | 0 | 307.49 | 19.506 | 18.914 | 1.01 | 0.72 | 20 | 1.19 | 0.158 | 170.1 | 258.9 | 22.5 | 498.7 | 10,641.4 | 0 | Small_molecule | null | null | null | Supportive_metabolic | 6.88 | 2.98 | 1,361,851 | Prior_auth_required | 0 | 0 | 14.18 | 0 | 3,799 | High_value | 0.303 | 0.603 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 4 | 18 | 0 | 0 | 0 | Assisted | Limited_verbal | 0 | 0 | Special_ed | 1 | 0 | 0 | null | null | 0 | 69 | 13.5 | 5.5 | 1 | 10,466 | 5.2 | 4,576 | 33.8 | 48.1 | 46.4 | 59.4 | 63.7 | 21.6 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 159 | 12 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 3.68 |
HCG5-0000233 | Male | Hispanic | North_America | Rural | Low | English | Commercial | SMA_type2 | NM | 83,418 | 253,550 | AR | 5.26 | 0.25 | 0.003 | 0.003 | 0 | 0 | 5 | 11 | 1 | 0 | 1 | 1 | 1 | WES | 6.94 | 1 | 4,500 | 1 | NBS_followup | 9,136.74 | 6.75 | Delayed | 66.1 | 64.5 | 61.4 | 87.7 | 119.6 | 0 | 0 | 0 | 3.37 | 8 | 0 | null | 1 | 61.1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -2.17 | -0.1 | 0 | 0 | 1 | 0 | 41.08 | 15.049 | 31.22 | 1.51 | 2.22 | 88.8 | 4.01 | 0.189 | 728.3 | 158.8 | 38.6 | 236 | 1,636.5 | 1 | Supportive_only | null | null | null | null | null | 10.6 | 0 | Fully_covered | 0 | 0 | 5.16 | 0 | 55 | High_value | 0.362 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 2 | 17 | 4 | 0 | 1 | Assisted | Limited_verbal | 0 | 0 | Home_school_medical | 1 | 0 | 1 | 6.37 | Cardiac | 0 | 44.1 | 15.7 | 14 | 0 | 0 | 5.7 | 59,016 | 44.2 | 51.1 | 40.1 | 51.3 | 43.2 | 33.1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 201.8 | 10 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 0.52 |
HCG5-0000234 | Male | White_non_Hispanic | Latin_America | Suburban | Low | English | Medicaid | Angelman | SYN | 72 | 105,830 | AD | 4.94 | 0.08 | 1.228 | 11.58 | 10.352 | 2 | 12 | 17 | 4 | 1 | 0 | 0 | null | WES | 4.18 | 0 | 4,500 | 1 | Geneticist | 35,212.32 | 5.11 | Delayed | 79.9 | 47 | 75.4 | 69.4 | 67.5 | 0 | 1 | 1 | 1.08 | 3 | 0 | null | 0 | 53.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.22 | 1.07 | 0 | 0 | 0 | 0 | 217.08 | 19.734 | 16.31 | 2.45 | 1.42 | 175.2 | 5.38 | 0.171 | 106.6 | 418.9 | 61.8 | 72.7 | 391.1 | 0 | Supportive_only | null | null | null | null | null | 7.86 | 0 | Fully_covered | 0 | 0 | 1.45 | 0 | 1,759 | Low_value | 0.46 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 0 | 40 | 2 | 1 | 0 | Assisted | Limited_verbal | 0 | 0 | Mainstream_with_support | 1 | 1 | 0 | null | null | 0 | 32.3 | 8.7 | 12.2 | 1 | 23,897 | 7.2 | 2,579 | 70.9 | 73.6 | 53 | 76.6 | 40.5 | 49.6 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 34.5 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HCG5-0000235 | Male | White_non_Hispanic | Asia_Pacific | Rural | Middle | English | Other_public | SCID | IMM | 183 | 300,400 | XLR | 9.5 | 0.92 | 0.003 | 0.003 | 0 | 0 | 2 | 14 | 6 | 0 | 1 | 1 | 1 | WGS | 0.92 | 0 | 8,500 | 0 | NBS_followup | 46,950.23 | 7.88 | Profound_delay | 53.5 | 14.7 | 10 | 73 | 35 | 0 | 0 | 0 | 1.15 | 4 | 1 | Moderate | 0 | 114.9 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | -1.75 | -0.01 | 0 | 0 | 0 | 0 | 337.13 | 20.255 | 2.975 | 3.12 | 1.04 | 20 | 0.85 | 0.146 | 141.2 | 423.3 | 30.7 | 34.3 | 4,792.4 | 1 | ASO | null | null | Custom_ASO | null | 1.28 | 5.5 | 186,721 | Denied | 0 | 0 | 11.88 | 1 | 14,837 | Intermediate | 0.412 | 0.855 | 0 | 0 | Responder | 1 | MUD | 1 | 0 | Stable | 3 | 23 | 2 | 0 | 0 | Bedbound | Nonverbal | 1 | 1 | Mainstream | 1 | 0 | 1 | 2.37 | Cardiac | 1 | 47 | 15 | 15.1 | 1 | 38,142 | 5 | 1,831 | 36.3 | 15.1 | 67.6 | 57.4 | 26.1 | 24.5 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 53.7 | 5 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
HCG5-0000236 | Male | White_non_Hispanic | Latin_America | Urban | Low | Other | Medicaid | Leigh_syndrome | MITO | 506 | 256,000 | MT | 7.27 | 0.68 | 2.136 | 6.93 | 4.794 | 2 | 12 | 10 | 2 | 1 | 0 | 0 | null | WES | 1.64 | 0 | 4,500 | 1 | Neurologist | 20,846.75 | 4.63 | Regression | 58.5 | 56.5 | 84.9 | 78.4 | 40.1 | 1 | 0 | 1 | 2.42 | 3 | 1 | Moderate | 1 | 52.6 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | -2.1 | -0.39 | 0 | 0 | 0 | 0 | 36.44 | 16.651 | 4.792 | 4.25 | 9.61 | 302.9 | 2.55 | 0.154 | 286 | 596.2 | 24.2 | 97.7 | 533.4 | 0 | Supportive_only | null | null | null | null | null | 14.09 | 0 | Fully_covered | 0 | 0 | 3.63 | 0 | 5,680 | Intermediate | 0.663 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 2 | 14 | 1 | 0 | 0 | Wheelchair | AAC_device | 0 | 0 | Mainstream | 1 | 3 | 0 | null | null | 1 | 74.9 | 12.1 | 6.4 | 1 | 45,981 | 6.3 | 3,496 | 47.2 | 31 | 52.6 | 87.1 | 30.4 | 44.9 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 543.9 | 17 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 6.52 |
HCG5-0000237 | Male | White_non_Hispanic | North_America | Urban | Middle | English | Commercial | Hypophosphatasia | SKEL | 436 | 241,500 | AR | 6.35 | 0.25 | 0.01 | 1.231 | 1.221 | 1 | 15 | 21 | 2 | 1 | 0 | 0 | null | WES | 19.27 | 0 | 4,500 | 1 | Geneticist | 60,074.78 | 5.17 | Regression | 39.3 | 86.4 | 76.2 | 67.9 | 122.3 | 0 | 0 | 0 | 2.31 | 1 | 0 | null | 0 | 55.1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | -1.6 | -1.36 | 0 | 1 | 0 | 0 | 241.12 | 18.31 | 10.898 | 4.36 | 6.84 | 174.4 | 1.4 | 0.165 | 678.6 | 568.2 | 32.4 | 279.8 | 7,049.8 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 4.73 | 1.26 | 1,816,331 | Partial_coverage | 0 | 0 | 12.11 | 1 | 1,641 | Intermediate | 0.297 | 0.767 | 0 | 0 | Partial | 0 | null | 0 | 0 | Slow_progression | 7 | 11 | 2 | 1 | 0 | Wheelchair | AAC_device | 1 | 0 | Special_ed | 1 | 6 | 0 | null | null | 0 | 35.3 | 11.3 | 13.2 | 0 | 0 | 2.6 | 8,796 | 64.9 | 64.6 | 48.3 | 62.5 | 82.2 | 25.7 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 67.8 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
HCG5-0000238 | Male | White_non_Hispanic | Europe | Urban | Middle | English | Commercial | Gaucher_type1 | LSD | 355 | 230,800 | AR | 5.1 | 0.05 | 3.783 | 6.336 | 2.553 | 0 | 6 | 8 | 4 | 0 | 0 | 0 | null | Single_gene | 25.74 | 1 | 800 | 0 | Neurologist | 13,135.86 | 6.5 | Delayed | 33.2 | 70.3 | 50.8 | 64.7 | 73.3 | 0 | 1 | 0 | 2 | 7 | 0 | null | 0 | 59.9 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | -1.86 | -0.98 | 0 | 0 | 1 | 0 | 92.29 | 7.589 | 9.732 | 4.31 | 1.39 | 20 | 2.31 | 0.081 | 126.9 | 1,026.3 | 96.8 | 66.6 | 1,779 | 1 | ERT | Taliglucerase | null | null | null | 6.39 | 58.17 | 539,365 | Prior_auth_required | 0 | 0 | 6.4 | 1 | 213 | High_value | 0.517 | 0.706 | 0 | 0 | Responder | 0 | null | 0 | 0 | Slow_progression | 0 | 18 | 1 | 0 | 0 | Assisted | Limited_verbal | 0 | 0 | Special_ed | 0 | 1 | 0 | null | null | 0 | 43.7 | 12.5 | 14.6 | 1 | 82,402 | 5.2 | 15,465 | 61.5 | 53.4 | 36.6 | 41.6 | 60.6 | 25.7 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 185.7 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 |
HCG5-0000239 | Male | White_non_Hispanic | Asia_Pacific | Urban | Middle | English | Medicaid_CHIP | Fabry | LSD | 324 | 301,500 | XLR | 5.34 | 0.04 | 11.483 | 15.02 | 3.537 | 1 | 5 | 22 | 1 | 1 | 0 | 0 | null | Panel | 4.07 | 0 | 1,500 | 1 | Neurologist | 18,774.92 | 5.83 | Delayed | 61.9 | 103.2 | 63.3 | 58.7 | 93.6 | 0 | 0 | 0 | 1.17 | 6 | 1 | Moderate | 1 | 72.9 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -0.82 | -1.14 | 0 | 0 | 1 | 0 | 311.75 | 13.312 | 9.911 | 11.19 | 1.06 | 341.4 | 2.11 | 0.249 | 563.5 | 273 | 96.2 | 721.4 | 505.8 | 1 | Gene_therapy | null | Clinical_trial | null | null | 17.78 | 19.55 | 5,000,000 | Fully_covered | 0 | 0 | 9.66 | 1 | 1,271 | High_value | 0.467 | 0.591 | 0 | 0 | Responder | 0 | null | 0 | 0 | Slow_progression | 4 | 21 | 1 | 0 | 1 | Assisted | Limited_verbal | 0 | 0 | Home_school_medical | 1 | 1 | 1 | 18 | Respiratory_failure | 1 | 63.3 | 21.6 | 3.6 | 1 | 54,049 | 6.7 | 13,268 | 56.7 | 74.9 | 74.7 | 34 | 38.1 | 64 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 135.7 | 10 | 0 | 0 | 1 | 0 | 0 | 1 | 3 | 5.26 |
HCG5-0000240 | Male | Hispanic | North_America | Urban | Low | Other | Medicaid | WAS_Wiskott | IMM | 906 | 301,000 | XLR | 6.24 | 0.55 | 0.454 | 5.034 | 4.58 | 0 | 11 | 24 | 3 | 0 | 0 | 0 | null | Panel | 46.3 | 0 | 1,500 | 1 | Metabolic_specialist | 20,498.97 | 7.26 | Regression | 76.9 | 58.2 | 44.6 | 70.1 | 79.1 | 0 | 1 | 0 | 1.63 | 4 | 1 | Mild | 0 | 51.4 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0.1 | -0.38 | 1 | 0 | 0 | 0 | 71.26 | 5.272 | 9.6 | 1.17 | 3.03 | 20 | 1 | 0.19 | 322.9 | 436.1 | 32 | 81.4 | 4,110.6 | 1 | Supportive_only | null | null | null | null | null | 1.32 | 0 | Partial_coverage | 0 | 0 | 14.97 | 0 | 726 | Cost_saving | 0.134 | null | 1 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 1 | 10 | 0 | 0 | 0 | Wheelchair | AAC_device | 0 | 0 | Special_ed | 1 | 0 | 0 | null | null | 0 | 48.1 | 17.6 | 7.5 | 0 | 0 | 7 | 4,277 | 49.9 | 48.5 | 90.1 | 59.4 | 67.8 | 51.6 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 181.6 | 15 | 0 | 1 | 0 | 1 | 1 | 0 | 10 | 6.81 |
HCG5-0000241 | Male | White_non_Hispanic | North_America | Urban | High | English | Medicaid | Diastrophic | SKEL | 628 | 222,600 | AR | 5.67 | 0.1 | 0.015 | 0.723 | 0.708 | 1 | 19 | 15 | 1 | 0 | 0 | 0 | null | Panel | 5.37 | 0 | 1,500 | 1 | Other | 16,571.57 | 6.23 | Delayed | 71.2 | 65.4 | 66.6 | 60.5 | 115.7 | 0 | 0 | 0 | 1.39 | 3 | 0 | null | 1 | 61.1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | -1.82 | -3.43 | 0 | 0 | 0 | 0 | 514.01 | 32.233 | 2.402 | 5.85 | 1.01 | 20 | 4.6 | 0.129 | 366.6 | 258.8 | 63.8 | 39.8 | 3,044.8 | 0 | Supportive_only | null | null | null | null | null | 19.3 | 0 | Partial_coverage | 0 | 0 | 1.41 | 0 | 1,434 | Intermediate | 0.436 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 1 | 33 | 3 | 0 | 1 | Assisted | Limited_verbal | 0 | 0 | Special_ed | 1 | 2 | 0 | null | null | 0 | 41.1 | 19 | 2.8 | 1 | 50,209 | 4.5 | 18,456 | 70.3 | 55.9 | 44.6 | 10.9 | 76.1 | 46 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 163.7 | 15 | 1 | 0 | 0 | 0 | 0 | 0 | 5 | 0 |
HCG5-0000242 | Female | White_non_Hispanic | North_America | Urban | Low | Other | Commercial | MPS_III_Sanfilippo | LSD | 581 | 252,900 | AR | 8.98 | 0.7 | 2.104 | 5.795 | 3.691 | 0 | 7 | 16 | 3 | 0 | 0 | 0 | null | Metabolic | 7.83 | 0 | 900 | 0 | Geneticist | 4,718.47 | 3.98 | Profound_delay | 46 | 25.5 | 38.4 | 52.1 | 42.5 | 0 | 0 | 1 | 0.46 | 0 | 0 | null | 1 | 45.6 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | -2.55 | 1.25 | 0 | 0 | 1 | 1 | 142.09 | 23.856 | 25.156 | 5.83 | 2.67 | 95.3 | 2.03 | 0.209 | 87.7 | 581.2 | 44.1 | 244.9 | 216.3 | 0 | Supportive_only | null | null | null | null | null | 16.24 | 0 | Fully_covered | 0 | 0 | 7.51 | 0 | 47 | High_value | 0.404 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Moderate | 4 | 11 | 2 | 1 | 0 | Bedbound | Nonverbal | 1 | 0 | Special_ed | 1 | 2 | 0 | null | null | 0 | 59.8 | 15.9 | 7.2 | 0 | 0 | 6.1 | 3,572 | 35.6 | 34.8 | 41.9 | 42.1 | 26.8 | 45.1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2.7 | 31 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 3.64 |
HCG5-0000243 | Male | White_non_Hispanic | MENA | Urban | Middle | English | Commercial | Alpers | MITO | 726 | 203,700 | AR | 6.97 | 0.75 | 2.955 | 9.882 | 6.928 | 5 | 6 | 10 | 0 | 1 | 0 | 0 | null | Panel | 12.42 | 0 | 1,500 | 1 | Geneticist | 26,312.51 | 6.24 | Regression | 54.6 | 50.2 | 56 | 66.5 | 35.2 | 0 | 0 | 1 | 1.7 | 1 | 0 | null | 0 | 83.7 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | -3.52 | 2.71 | 0 | 0 | 0 | 0 | 98.01 | 19.879 | 21.424 | 1.63 | 3.54 | 157.3 | 1.68 | 0.135 | 154.2 | 229.6 | 109.8 | 565 | 1,696.9 | 0 | Small_molecule | null | null | null | Supportive_metabolic | 10.4 | 49.99 | 165,912 | Fully_covered | 0 | 0 | 6.58 | 1 | 2,330 | Low_value | 0.331 | 0.804 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 10 | 19 | 1 | 0 | 0 | Wheelchair | AAC_device | 0 | 0 | Special_ed | 1 | 0 | 1 | 18 | Infection | 0 | 40.9 | 23.7 | 10.2 | 1 | 36,645 | 6.7 | 110,089 | 58.2 | 71.9 | 40.6 | 42.9 | 41.1 | 55.6 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 30.5 | 7 | 1 | 0 | 0 | 0 | 0 | 0 | 4 | 0 |
HCG5-0000244 | Male | White_non_Hispanic | Asia_Pacific | Urban | Middle | English | Medicaid | SMA_type3 | NM | 83,419 | 253,400 | AR | 4.76 | 0.04 | 6.128 | 14.828 | 8.7 | 4 | 6 | 6 | 3 | 1 | 1 | 0 | null | WES | 54.28 | 0 | 4,500 | 1 | Metabolic_specialist | 24,257.8 | 7.47 | Delayed | 74.6 | 47.9 | 45.1 | 64.7 | 113.3 | 0 | 1 | 0 | 6.93 | 5 | 0 | null | 1 | 40.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.02 | -1.09 | 0 | 0 | 0 | 0 | 88.01 | 49.285 | 19.495 | 6.87 | 4.37 | 42 | 2.39 | 0.135 | 218.7 | 576.4 | 51.1 | 1,263.7 | 2,437.8 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 15.38 | 66.45 | 930,498 | Denied | 0 | 0 | 8.66 | 0 | 631 | Intermediate | 0.739 | 0.742 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 4 | 23 | 0 | 0 | 0 | Assisted | Limited_verbal | 0 | 0 | Special_ed | 1 | 6 | 0 | null | null | 0 | 52.5 | 17.8 | 3 | 1 | 21,697 | 4.8 | 17,574 | 53 | 69 | 78 | 43.4 | 53.3 | 41.2 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 39.2 | 5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HCG5-0000245 | Male | White_non_Hispanic | Europe | Urban | Middle | English | Commercial | EB_simplex | DERM | 304 | 131,800 | AD | 3.64 | 0.04 | 0.016 | 0.281 | 0.265 | 1 | 15 | 8 | 7 | 0 | 0 | 0 | null | null | 4.67 | 1 | 0 | 0 | Metabolic_specialist | 70,994.98 | 8.75 | Delayed | 58.4 | 48.1 | 64.4 | 97.2 | 98.8 | 0 | 0 | 0 | 5.58 | 7 | 1 | Moderate | 0 | 67 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | -2.88 | 1.48 | 0 | 0 | 0 | 0 | 434.42 | 10.204 | 17.935 | 6.04 | 4.51 | 20 | 1.32 | 0.192 | 366.9 | 252.6 | 38.8 | 41.6 | 2,299.7 | 0 | Supportive_only | null | null | null | null | null | 72 | 0 | Fully_covered | 0 | 0 | 10.53 | 0 | 6,131 | High_value | 0.651 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 1 | 18 | 0 | 0 | 0 | Ambulatory | Verbal | 0 | 0 | Home_school_medical | 1 | 2 | 0 | null | null | 0 | 11.1 | 3.5 | 15.5 | 1 | 40,820 | 3.8 | 800 | 70.5 | 32.3 | 84.5 | 64.7 | 39 | 35.9 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 75.3 | 16 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0.47 |
HCG5-0000246 | Male | Black_non_Hispanic | Asia_Pacific | Urban | Low | English | Medicaid | SMA_type3 | NM | 83,419 | 253,400 | AR | 4.65 | 0.04 | 0.028 | 0.028 | 0 | 0 | 3 | 12 | 10 | 0 | 1 | 1 | 10.2 | WES | 1.48 | 1 | 4,500 | 1 | NBS_followup | 8,456.16 | 6.38 | Delayed | 83.8 | 48.9 | 91.5 | 65.4 | 83.1 | 0 | 0 | 0 | 1.87 | 8 | 0 | null | 0 | 77.3 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1.02 | -0.61 | 0 | 0 | 0 | 0 | 87.96 | 11.708 | 9.434 | 4.33 | 1.64 | 25.4 | 1.99 | 0.293 | 92.9 | 535.5 | 137 | 1,171.5 | 1,503.1 | 1 | Gene_therapy | null | Onasemnogene_abeparvovec | null | null | 0.27 | 7.35 | 2,392,660 | Prior_auth_required | 0 | 0 | 7.67 | 0 | 103 | Cost_saving | 0.283 | 0.63 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 5 | 21 | 1 | 0 | 0 | Assisted | Limited_verbal | 0 | 1 | Mainstream_with_support | 1 | 1 | 0 | null | null | 0 | 21.2 | 16.8 | 15.8 | 1 | 51,910 | 4.2 | 3,688 | 69.5 | 64.3 | 65.6 | 39 | 42.5 | 65.5 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 20.7 | 20 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.26 |
HCG5-0000247 | Male | White_non_Hispanic | Europe | Suburban | Low | Mandarin | Commercial | CPS1 | UCD | 147 | 237,300 | AR | 9.37 | 0.62 | 0.01 | 1.735 | 1.725 | 4 | 15 | 10 | 8 | 1 | 0 | 0 | null | Panel | 23.92 | 0 | 1,500 | 0 | Other | 15,131.49 | 5.25 | Profound_delay | 54.3 | 43.5 | 23.2 | 39.5 | 79.4 | 0 | 0 | 0 | 3.78 | 2 | 1 | Severe | 1 | 67.6 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1.54 | -1.36 | 0 | 0 | 1 | 0 | 523.45 | 5.853 | 7.054 | 0.65 | 3.54 | 21.5 | 0.74 | 0.185 | 51.9 | 667.3 | 23.4 | 300 | 3,808.5 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 2.31 | 18.08 | 251,297 | Partial_coverage | 0 | 0 | 3.73 | 0 | 11,134 | Cost_saving | 0.534 | 0.675 | 0 | 0 | Partial | 0 | null | 0 | 0 | Slow_progression | 1 | 24 | 2 | 1 | 0 | Bedbound | Nonverbal | 1 | 1 | Mainstream_with_support | 1 | 5 | 1 | 12.32 | Neurodegeneration | 0 | 46.2 | 15.8 | 10.7 | 1 | 19,163 | 3.9 | 2,819 | 48.5 | 58.4 | 30.7 | 17.7 | 30.7 | 42.6 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 48.5 | 15 | 1 | 1 | 0 | 0 | 1 | 0 | 2 | 5.92 |
HCG5-0000248 | Female | Asian | Europe | Urban | Middle | Other | Medicaid | HCU_homocystinuria | OA | 394 | 236,200 | AR | 5.29 | 0.08 | 0.003 | 0.003 | 0 | 0 | 2 | 5 | 2 | 0 | 1 | 1 | 1 | Metabolic | 1.95 | 0 | 900 | 0 | NBS_followup | 79,470.57 | 6.98 | Delayed | 59.2 | 53.2 | 10 | 47.1 | 80.6 | 0 | 0 | 0 | 3.63 | 1 | 0 | null | 1 | 48.6 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -2.06 | -1.01 | 1 | 1 | 1 | 0 | 224.4 | 55.741 | 4.875 | 9.69 | 10.51 | 118.8 | 0.54 | 0.121 | 20 | 167.8 | 55.9 | 123.6 | 3,193.7 | 0 | Supportive_only | null | null | null | null | null | 5.88 | 0 | Partial_coverage | 0 | 0 | 2.42 | 0 | 647 | Intermediate | 0.554 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Rapid | 8 | 12 | 3 | 0 | 0 | Assisted | Limited_verbal | 0 | 0 | Home_school_medical | 1 | 4 | 0 | null | null | 0 | 64.9 | 16.3 | 7 | 0 | 0 | 6.6 | 49,978 | 75.6 | 49.3 | 68.8 | 68.1 | 48.5 | 70.7 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 13.7 | 9 | 1 | 1 | 0 | 0 | 0 | 0 | 3 | 3.89 |
HCG5-0000249 | Female | Asian | Europe | Urban | Low | English | Medicaid | ASL | UCD | 23 | 207,900 | AR | 8.6 | 0.42 | 0.701 | 2.135 | 1.433 | 1 | 25 | 5 | 6 | 0 | 0 | 0 | null | Panel | 20.19 | 1 | 1,500 | 1 | Geneticist | 35,030 | 4.89 | Profound_delay | 52 | 37.2 | 36.7 | 39 | 84.7 | 0 | 1 | 0 | 2.18 | 1 | 0 | null | 0 | 97.3 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -3.8 | -0.26 | 1 | 1 | 1 | 0 | 45.35 | 38.282 | 48.844 | 5.37 | 0.5 | 20.7 | 1.24 | 0.144 | 598.8 | 186.1 | 116.3 | 517.4 | 1,865.2 | 1 | SRT | null | null | null | null | 2.36 | 29.26 | 1,481,344 | Partial_coverage | 0 | 0 | 1.6 | 1 | 154 | High_value | 0.446 | 0.403 | 0 | 0 | Non_responder | 0 | null | 0 | 0 | Moderate | 4 | 52 | 4 | 1 | 0 | Bedbound | Nonverbal | 1 | 0 | Home_school_medical | 1 | 0 | 1 | 7.79 | Cardiac | 1 | 46.6 | 4.6 | 10.9 | 1 | 7,933 | 5.9 | 2,363 | 60.9 | 54 | 59.3 | 43.6 | 100 | 43 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 5.9 | 17 | 1 | 0 | 0 | 0 | 1 | 0 | 7 | 1.64 |
HCG5-0000250 | Male | White_non_Hispanic | Europe | Urban | Low | Other | Medicaid | Congenital_myopathy | NM | 97,245 | 160,150 | AR | 7.45 | 0.18 | 1.131 | 5.202 | 4.071 | 0 | 16 | 5 | 1 | 0 | 0 | 0 | null | Single_gene | 23.61 | 0 | 800 | 1 | Cardiologist | 44,110 | 9.07 | Regression | 20.7 | 61.6 | 98.5 | 92.6 | 62.2 | 1 | 0 | 0 | 6.35 | 6 | 1 | Mild | 1 | 49.7 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -1.02 | -1.55 | 0 | 0 | 1 | 0 | 186.04 | 73.452 | 11.96 | 6.19 | 4.45 | 20 | 1.62 | 0.232 | 759.7 | 410.5 | 71.3 | 1,086.7 | 1,427.4 | 0 | Supportive_only | null | null | null | null | null | 0.93 | 0 | Partial_coverage | 0 | 0 | 7.45 | 0 | 8,471 | Intermediate | 0.222 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Rapid | 2 | 61 | 1 | 0 | 1 | Wheelchair | AAC_device | 1 | 0 | Special_ed | 1 | 6 | 0 | null | null | 0 | 47.2 | 4.5 | 18.2 | 1 | 100,141 | 5.3 | 632 | 46.1 | 69.5 | 63.4 | 60.2 | 26.5 | 63 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1,047.4 | 15 | 1 | 1 | 0 | 0 | 1 | 0 | 6 | 3.46 |
HCG5-0000251 | Male | White_non_Hispanic | North_America | Suburban | Middle | English | Commercial | EB_simplex | DERM | 304 | 131,800 | AD | 5.59 | 0.04 | 0.146 | 0.311 | 0.165 | 1 | 24 | 9 | 0 | 1 | 0 | 0 | null | Panel | 6.33 | 0 | 1,500 | 1 | Other | 40,460.86 | 6.61 | Delayed | 66.9 | 35.9 | 78.7 | 46.6 | 87.4 | 0 | 1 | 1 | 7.64 | 0 | 0 | null | 1 | 68.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.72 | 0.57 | 0 | 0 | 0 | 0 | 189.97 | 92.233 | 2.733 | 0.3 | 1.15 | 20 | 0.78 | 0.194 | 21.9 | 389.3 | 26.2 | 38.6 | 2,096.7 | 0 | Small_molecule | null | null | null | Supportive_metabolic | 2.21 | 2.45 | 93,566 | Partial_coverage | 0 | 0 | 10.74 | 0 | 17,860 | High_value | 0.249 | 0.792 | 0 | 0 | Responder | 0 | null | 0 | 0 | Moderate | 0 | 38 | 0 | 0 | 1 | Assisted | Limited_verbal | 0 | 0 | Special_ed | 1 | 3 | 0 | null | null | 0 | 50 | 12.1 | 13.5 | 0 | 0 | 4.7 | 16,605 | 59.8 | 47.1 | 41 | 61.1 | 18.7 | 53.6 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 34 | 29 | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 2.02 |
HCG5-0000252 | Male | White_non_Hispanic | Latin_America | Urban | High | English | Medicaid_CHIP | Leigh_syndrome | MITO | 506 | 256,000 | MT | 8.98 | 0.68 | 0.01 | 1.188 | 1.178 | 1 | 13 | 20 | 0 | 1 | 0 | 0 | null | Panel | 59.61 | 0 | 1,500 | 1 | Metabolic_specialist | 40,622.79 | 4.34 | Profound_delay | 39.2 | 45.8 | 24.8 | 49.9 | 59.5 | 0 | 0 | 0 | 1.51 | 1 | 0 | null | 0 | 97.1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | -3.37 | -1.23 | 0 | 0 | 0 | 0 | 43.9 | 15.151 | 11.866 | 2.93 | 11.75 | 20 | 1.65 | 0.243 | 268 | 315.4 | 25.2 | 152.3 | 988.6 | 0 | Supportive_only | null | null | null | null | null | 6.19 | 0 | Partial_coverage | 0 | 0 | 4.91 | 0 | 4,657 | Intermediate | 0.515 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 1 | 29 | 2 | 0 | 0 | Bedbound | Nonverbal | 1 | 0 | Mainstream_with_support | 1 | 5 | 1 | 10.22 | Other | 1 | 43.4 | 3.2 | 2.2 | 1 | 9,333 | 7.1 | 339 | 52.1 | 45.8 | 32.9 | 60.7 | 64.1 | 61.2 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 222 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1.43 |
HCG5-0000253 | Male | Black_non_Hispanic | Asia_Pacific | Suburban | Low | English | Commercial | MPS_VI_Maroteaux | LSD | 583 | 253,200 | AR | 8.32 | 0.32 | 0.472 | 3.753 | 3.281 | 1 | 10 | 23 | 4 | 1 | 0 | 0 | null | WGS | 9.86 | 0 | 8,500 | 1 | Geneticist | 138,544.24 | 6.17 | Profound_delay | 68.6 | 64.5 | 40.7 | 37.3 | 44.6 | 0 | 0 | 0 | 3.42 | 4 | 0 | null | 1 | 43.1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0.48 | -2.12 | 0 | 0 | 1 | 1 | 182.78 | 11.704 | 1.867 | 1.42 | 6.93 | 31 | 1.62 | 0.193 | 155.6 | 287.7 | 16.7 | 134.4 | 650.3 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 4.44 | 9.33 | 97,505 | Prior_auth_required | 0 | 0 | 14.12 | 0 | 3,073 | Low_value | 0.511 | 0.624 | 0 | 0 | Partial | 0 | null | 0 | 0 | Stable | 0 | 11 | 3 | 0 | 0 | Bedbound | Nonverbal | 1 | 1 | Special_ed | 1 | 4 | 0 | null | null | 0 | 26.1 | 17.7 | 0 | 0 | 0 | 5.5 | 4,235 | 66.2 | 31.4 | 24.5 | 55.8 | 48.2 | 56.3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 146.7 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0.2 |
HCG5-0000254 | Female | White_non_Hispanic | North_America | Rural | High | English | Medicaid_CHIP | MPS_IV_Morquio | LSD | 582 | 253,000 | AR | 6.96 | 0.3 | 2.533 | 11.874 | 9.34 | 4 | 8 | 19 | 2 | 1 | 0 | 0 | null | Panel | 8.64 | 0 | 1,500 | 1 | Metabolic_specialist | 29,213.51 | 6.25 | Regression | 51.2 | 74.6 | 65.5 | 12.7 | 55.1 | 0 | 0 | 0 | 2.77 | 6 | 0 | null | 0 | 67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -4.02 | -0.43 | 0 | 0 | 1 | 1 | 311.74 | 4.411 | 15.229 | 12.61 | 6.73 | 20 | 2.14 | 0.225 | 1,054.1 | 238 | 126.2 | 487.2 | 587.7 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 12.76 | 11.94 | 186,849 | Prior_auth_required | 0 | 0 | 6.03 | 0 | 1,053 | Cost_saving | 0.369 | 0.753 | 0 | 0 | Partial | 0 | null | 0 | 0 | Moderate | 0 | 38 | 0 | 1 | 0 | Wheelchair | AAC_device | 0 | 0 | Home_school_medical | 1 | 5 | 0 | null | null | 0 | 57.2 | 14 | 6.2 | 0 | 0 | 6.2 | 13,550 | 26.2 | 55.7 | 80 | 66.2 | 40.8 | 62 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 34.6 | 5 | 1 | 0 | 1 | 0 | 0 | 0 | 4 | 2.8 |
HCG5-0000255 | Male | Hispanic | Europe | Urban | Middle | Mandarin | Medicaid | OI_type1_to_4 | SKEL | 666 | 166,200 | AD | 3.5 | 0.06 | 0.01 | 2.857 | 2.847 | 0 | 22 | 5 | 4 | 0 | 0 | 0 | null | WGS | 42.42 | 0 | 8,500 | 0 | Geneticist | 10,826.92 | 3.97 | Delayed | 92.9 | 88.1 | 38.6 | 87.9 | 71.1 | 0 | 0 | 0 | 4.34 | 0 | 1 | Moderate | 0 | 109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -3.55 | -1.51 | 0 | 0 | 0 | 1 | 560.12 | 8.263 | 13.855 | 1.85 | 1.54 | 20 | 3.22 | 0.37 | 190.1 | 430.8 | 20.2 | 1,219.3 | 1,636 | 1 | Chaperone | null | null | null | null | 3.45 | 40.52 | 86,037 | Fully_covered | 0 | 0 | 6.19 | 1 | 2,955 | Intermediate | 0.657 | 0.706 | 0 | 0 | Responder | 0 | null | 0 | 0 | Moderate | 4 | 12 | 2 | 1 | 0 | Ambulatory | Verbal | 0 | 0 | Special_ed | 1 | 2 | 0 | null | null | 1 | 48.5 | 23.7 | 9.7 | 1 | 29,320 | 4.7 | 4,116 | 80.4 | 36.6 | 87.5 | 96.1 | 75.3 | 71.1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 292.4 | 12 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 0.7 |
HCG5-0000256 | Male | Hispanic | North_America | Rural | High | English | Medicaid | SCID | IMM | 183 | 300,400 | XLR | 8.05 | 0.92 | 0.019 | 0.019 | 0 | 0 | 2 | 7 | 1 | 0 | 1 | 1 | 6.8 | Single_gene | 0.59 | 0 | 800 | 0 | NBS_followup | 47,806.54 | 7.69 | Profound_delay | 40.6 | 49.1 | 25.7 | 37.1 | 59.2 | 0 | 0 | 0 | 0.53 | 1 | 0 | null | 1 | 37.1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | -1.43 | -0.92 | 0 | 0 | 0 | 0 | 536.11 | 16.57 | 7.48 | 14.63 | 4.21 | 144.3 | 6.22 | 0.096 | 470.9 | 225.4 | 73.7 | 265.3 | 766.8 | 1 | Chaperone | null | null | null | null | 0.14 | 4.88 | 182,949 | Fully_covered | 0 | 0 | 1.83 | 0 | 5,793 | High_value | 0.689 | 0.687 | 0 | 0 | Partial | 1 | MSD | 1 | 1 | Moderate | 10 | 36 | 0 | 0 | 0 | Bedbound | Nonverbal | 1 | 0 | Mainstream_with_support | 1 | 1 | 1 | 7.12 | Cardiac | 1 | 53.2 | 15.7 | 2.5 | 0 | 0 | 4.4 | 25,209 | 21.8 | 55.1 | 25.1 | 58.8 | 18 | 37.4 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 20.5 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1.13 |
HCG5-0000257 | Male | Hispanic | MENA | Suburban | Middle | English | Medicaid | Fabry | LSD | 324 | 301,500 | XLR | 4.75 | 0.04 | 6.412 | 18 | 14.692 | 1 | 14 | 25 | 3 | 1 | 0 | 0 | null | MLPA | 15.18 | 1 | 1,000 | 1 | Neurologist | 16,156.92 | 6.63 | Delayed | 28 | 58.7 | 75.1 | 75.2 | 62.4 | 1 | 0 | 0 | 3.18 | 8 | 1 | Mild | 1 | 66 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | -0.58 | -0.49 | 0 | 1 | 0 | 0 | 1,976.4 | 3.473 | 5.23 | 9.6 | 4.65 | 20 | 2.88 | 0.433 | 146.9 | 438.4 | 16.5 | 177.4 | 1,542.6 | 1 | ASO | null | null | Custom_ASO | null | 18 | 2.41 | 73,521 | Prior_auth_required | 0 | 0 | 4.49 | 0 | 1,262 | Low_value | 0.687 | 0.689 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 0 | 63 | 0 | 0 | 1 | Assisted | Limited_verbal | 1 | 0 | Mainstream | 1 | 5 | 0 | null | null | 0 | 30.2 | 16.6 | 9.2 | 0 | 0 | 7 | 9,005 | 66 | 82.5 | 47.3 | 70.6 | 60.1 | 72.6 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 50.3 | 10 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.86 |
HCG5-0000258 | Male | Black_non_Hispanic | Latin_America | Urban | Middle | English | Uninsured | Gaucher_type2_3 | LSD | 77,259 | 230,900 | AR | 7.9 | 0.72 | 0.01 | 5.271 | 5.261 | 2 | 14 | 3 | 1 | 1 | 0 | 0 | null | Single_gene | 5.35 | 0 | 800 | 1 | Metabolic_specialist | 24,368.75 | 6.65 | Regression | 44.6 | 49.5 | 78.2 | 67.5 | 63.8 | 1 | 0 | 1 | 2.01 | 2 | 0 | null | 1 | 55.7 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | -1.88 | -2.54 | 0 | 0 | 0 | 0 | 181.38 | 8.418 | 20.21 | 5.35 | 0.39 | 20 | 1.23 | 0.24 | 107.3 | 273.9 | 267.7 | 399.4 | 6,836.9 | 1 | HSCT | null | null | null | null | 7.66 | 6.51 | 98,701 | Fully_covered | 0 | 0 | 15.31 | 1 | 812 | High_value | 0.687 | 0.685 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 1 | 25 | 2 | 0 | 0 | Wheelchair | AAC_device | 1 | 0 | Special_ed | 1 | 5 | 0 | null | null | 0 | 69.7 | 16.8 | 2.6 | 0 | 0 | 5.9 | 2,440 | 58 | 24.7 | 41.1 | 54.7 | 41.1 | 46.6 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 106.9 | 4 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | 3.36 |
HCG5-0000259 | Male | Other_Multi | Latin_America | Urban | Middle | English | Medicaid | SMA_type2 | NM | 83,418 | 253,550 | AR | 7.43 | 0.25 | 0.003 | 0.003 | 0 | 0 | 4 | 10 | 2 | 0 | 1 | 1 | 1 | MLPA | 12 | 0 | 1,000 | 0 | NBS_followup | 37,540.02 | 9.33 | Regression | 55.3 | 85.4 | 38.8 | 56.2 | 65.8 | 0 | 0 | 0 | 3.76 | 1 | 1 | Moderate | 1 | 44.8 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | -1.26 | 1.93 | 1 | 0 | 0 | 0 | 315.39 | 20.603 | 11.305 | 11.12 | 3.79 | 329.4 | 3.32 | 0.472 | 614.4 | 295.5 | 17.3 | 189.1 | 1,469.9 | 1 | Supportive_only | null | null | null | null | null | 5.12 | 0 | Prior_auth_required | 0 | 0 | 23.52 | 0 | 1,614 | Cost_saving | 0.417 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Rapid | 1 | 78 | 1 | 1 | 0 | Wheelchair | AAC_device | 0 | 0 | Special_ed | 1 | 0 | 0 | null | null | 0 | 41.9 | 13.7 | 10.9 | 1 | 33,648 | 6 | 7,560 | 47.7 | 70.5 | 74.4 | 15.7 | 47.2 | 22 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 56.6 | 20 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | 0.16 |
HCG5-0000260 | Female | White_non_Hispanic | North_America | Suburban | Middle | English | Other_public | Pompe_infantile | LSD | 365 | 232,300 | AR | 8.03 | 0.85 | 0.011 | 0.011 | 0 | 0 | 4 | 8 | 5 | 0 | 1 | 1 | 4 | Single_gene | 11.09 | 0 | 800 | 1 | NBS_followup | 12,845.91 | 7.45 | Profound_delay | 50.5 | 55.4 | 76.7 | 54 | 57.9 | 0 | 0 | 0 | 2.13 | 6 | 1 | Mild | 1 | 64.4 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | -0.47 | 0.9 | 0 | 0 | 1 | 0 | 98.87 | 49.605 | 2.122 | 2.11 | 5.77 | 120.1 | 5.16 | 0.112 | 892.5 | 670.4 | 46.1 | 22.5 | 2,075.9 | 1 | SRT | null | null | null | null | 0.33 | 18.33 | 505,553 | Fully_covered | 0 | 0 | 5.63 | 0 | 3,546 | Low_value | 0.18 | 0.731 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 2 | 21 | 2 | 0 | 0 | Bedbound | Nonverbal | 0 | 0 | Special_ed | 0 | 0 | 1 | 4.09 | Cardiac | 0 | 68.5 | 14.1 | 12.1 | 1 | 147,468 | 6.2 | 34,837 | 60.3 | 41.6 | 57.6 | 49.5 | 46 | 62.4 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 45.9 | 10 | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 1.55 |
HCG5-0000261 | Male | White_non_Hispanic | North_America | Rural | High | Spanish | Medicaid | WAS_Wiskott | IMM | 906 | 301,000 | XLR | 9.91 | 0.55 | 0.701 | 5.26 | 4.559 | 0 | 5 | 13 | 6 | 0 | 0 | 0 | null | Karyotype | 9.87 | 0 | 1,200 | 1 | Geneticist | 16,996.02 | 7.74 | Profound_delay | 38.6 | 36.5 | 14.8 | 19.1 | 47.4 | 0 | 0 | 0 | 4.56 | 2 | 0 | null | 0 | 118.1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | -0.34 | -1.41 | 0 | 0 | 0 | 0 | 1,193 | 11.642 | 35.999 | 2.43 | 0.93 | 153.8 | 1.14 | 0.193 | 53.4 | 588.3 | 104.4 | 432.1 | 1,438.4 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 8.11 | 53.38 | 375,977 | Fully_covered | 0 | 0 | 14.59 | 0 | 9,861 | Intermediate | 0.362 | 0.699 | 0 | 0 | Partial | 0 | null | 0 | 0 | Rapid | 1 | 25 | 0 | 1 | 0 | Bedbound | Nonverbal | 1 | 0 | Mainstream | 1 | 2 | 1 | 11.7 | Metabolic_crisis | 1 | 20.4 | 13.6 | 20 | 1 | 27,084 | 7 | 7,777 | 23.8 | 23.9 | 81.5 | 75 | 92.7 | 66.2 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 6.4 | 21 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0.94 |
HCG5-0000262 | Male | White_non_Hispanic | North_America | Urban | Low | English | Medicaid | MMA | OA | 27 | 251,000 | AR | 7.38 | 0.45 | 0.015 | 0.015 | 0 | 0 | 2 | 15 | 0 | 0 | 1 | 1 | 5.5 | WGS | 1.85 | 0 | 8,500 | 1 | NBS_followup | 41,285.38 | 5.42 | Regression | 42.9 | 65 | 10 | 65.5 | 44.8 | 1 | 1 | 0 | 1.12 | 3 | 0 | null | 1 | 68.8 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | -2.55 | -0.43 | 1 | 1 | 0 | 0 | 74.37 | 24.908 | 5.229 | 9.37 | 5.71 | 74.2 | 1.17 | 0.176 | 963.8 | 221.7 | 27.3 | 723.6 | 6,677.6 | 0 | Supportive_only | null | null | null | null | null | 48.35 | 0 | Fully_covered | 0 | 0 | 23.88 | 0 | 6,825 | High_value | 0.399 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 8 | 40 | 2 | 0 | 1 | Wheelchair | AAC_device | 0 | 0 | Special_ed | 1 | 2 | 1 | 13.94 | Infection | 1 | 41.9 | 0 | 10.2 | 1 | 282,588 | 7.2 | 10,311 | 37.2 | 40.1 | 51.7 | 63.4 | 35.5 | 58.9 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 127.3 | 8 | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 2.52 |
HCG5-0000263 | Male | Asian | North_America | Urban | Low | English | Medicaid | Pompe_infantile | LSD | 365 | 232,300 | AR | 8.99 | 0.85 | 0.421 | 1.863 | 1.442 | 2 | 10 | 22 | 2 | 0 | 1 | 0 | null | WES | 11.08 | 0 | 4,500 | 0 | Cardiologist | 16,419.41 | 6.33 | Profound_delay | 35.7 | 45.2 | 52.7 | 38 | 41.7 | 1 | 0 | 0 | 2.21 | 2 | 1 | Moderate | 1 | 57.8 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | -2.84 | 0.62 | 0 | 0 | 1 | 0 | 1,140.52 | 118.793 | 3.72 | 2.11 | 3.63 | 229.5 | 0.95 | 0.235 | 76 | 235.9 | 66.3 | 797.2 | 9,488.1 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 2.33 | 33.06 | 5,000,000 | Fully_covered | 0 | 0 | 2.88 | 0 | 8,945 | Low_value | 0.307 | 0.734 | 0 | 0 | Responder | 0 | null | 0 | 0 | Moderate | 5 | 46 | 0 | 0 | 1 | Bedbound | Nonverbal | 1 | 1 | Home_school_medical | 1 | 5 | 1 | 18 | Cardiac | 1 | 70.5 | 20.4 | 9.5 | 1 | 185,634 | 4.4 | 9,695 | 28.4 | 40.2 | 28.6 | 40.5 | 24 | 46.8 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 149.4 | 25 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0.56 |
HCG5-0000264 | Female | Black_non_Hispanic | North_America | Suburban | Low | English | Medicaid | Rett | SYN | 778 | 312,750 | XLD | 6.7 | 0.12 | 1.244 | 8.668 | 7.424 | 3 | 16 | 8 | 2 | 1 | 0 | 0 | null | Single_gene | 7.78 | 1 | 800 | 1 | Geneticist | 64,604.98 | 5.76 | Regression | 36.2 | 62.8 | 64.5 | 18.5 | 24.4 | 1 | 0 | 1 | 2.38 | 2 | 0 | null | 1 | 90.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -0.54 | -0.07 | 0 | 0 | 0 | 0 | 1,003.19 | 4.369 | 41.38 | 1.55 | 11.51 | 126.1 | 1.59 | 0.199 | 20 | 538.6 | 36.7 | 68.6 | 1,130.6 | 0 | Supportive_only | null | null | null | null | null | 5.33 | 0 | Prior_auth_required | 0 | 0 | 8.9 | 0 | 161 | Intermediate | 0.351 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 4 | 17 | 2 | 1 | 0 | Wheelchair | AAC_device | 0 | 1 | Special_ed | 1 | 3 | 0 | null | null | 0 | 45.4 | 19.8 | 17.3 | 1 | 14,722 | 5.5 | 2,958 | 41.3 | 38.6 | 44.6 | 62.6 | 60.1 | 35.3 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 32.2 | 12 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 4.36 |
HCG5-0000265 | Male | Hispanic | North_America | Urban | High | English | Commercial | Pompe_late_onset | LSD | 365 | 232,300 | AR | 4.3 | 0.1 | 0.012 | 0.012 | 0 | 0 | 2 | 27 | 2 | 1 | 1 | 1 | 4.2 | WES | 1.24 | 0 | 4,500 | 1 | NBS_followup | 11,075.14 | 8.32 | Delayed | 36.1 | 68.7 | 85.4 | 87.8 | 72.4 | 0 | 0 | 0 | 3.94 | 7 | 1 | Mild | 0 | 51.2 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | -1.25 | 2.61 | 0 | 1 | 0 | 0 | 82.69 | 58.985 | 31.615 | 3.47 | 2.29 | 22.6 | 2.78 | 0.191 | 247.9 | 178.2 | 58.7 | 477.2 | 3,743.6 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 0.63 | 8.35 | 83,936 | Fully_covered | 0 | 0 | 7.94 | 1 | 2,649 | Intermediate | 0.212 | 0.696 | 0 | 0 | Partial | 0 | null | 0 | 0 | Rapid | 5 | 35 | 4 | 0 | 0 | Assisted | Limited_verbal | 1 | 0 | Special_ed | 1 | 0 | 0 | null | null | 0 | 11.1 | 17.5 | 13.3 | 1 | 79,975 | 4.5 | 1,156 | 77.8 | 76.4 | 46.1 | 38.3 | 76.7 | 40 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 152.6 | 13 | 1 | 0 | 0 | 0 | 1 | 1 | 3 | 2.48 |
HCG5-0000266 | Male | White_non_Hispanic | Sub_Saharan_Africa | Suburban | Middle | English | Commercial | MMA | OA | 27 | 251,000 | AR | 7.35 | 0.45 | 0.016 | 0.016 | 0 | 0 | 6 | 12 | 1 | 0 | 1 | 1 | 5.9 | WES | 1.06 | 0 | 4,500 | 1 | NBS_followup | 11,041.63 | 7.44 | Regression | 50.3 | 46.6 | 63.2 | 73.8 | 35.7 | 0 | 1 | 0 | 2.9 | 4 | 0 | null | 0 | 63.5 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | -1.09 | -0.78 | 1 | 1 | 1 | 0 | 510.98 | 31.271 | 8.344 | 2.21 | 3.9 | 20 | 5.42 | 0.226 | 449.7 | 755.2 | 95.3 | 1,320.9 | 14,634.7 | 0 | Supportive_only | null | null | null | null | null | 15.91 | 0 | Denied | 0 | 0 | 17.59 | 0 | 1,391 | Low_value | 0.549 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 2 | 13 | 5 | 0 | 0 | Wheelchair | AAC_device | 1 | 0 | Not_enrolled | 0 | 3 | 1 | 8.97 | Other | 1 | 34.4 | 13.7 | 11.1 | 0 | 0 | 6 | 8,964 | 73.7 | 39 | 77.3 | 67.6 | 16.9 | 53.5 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 71.9 | 15 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.56 |
HCG5-0000267 | Male | Other_Multi | North_America | Urban | Middle | Spanish | Medicaid | Pompe_late_onset | LSD | 365 | 232,300 | AR | 5.53 | 0.1 | 5.956 | 18 | 15 | 0 | 6 | 20 | 1 | 0 | 1 | 0 | null | WES | 2.41 | 0 | 4,500 | 1 | Neurologist | 149,559.6 | 2.22 | Delayed | 50.6 | 84.6 | 65.3 | 92.2 | 70.1 | 1 | 0 | 0 | 5.09 | 8 | 0 | null | 0 | 77.8 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | -2.59 | 1.5 | 0 | 0 | 0 | 0 | 286.21 | 69.399 | 3.946 | 19.93 | 4.51 | 20 | 3.8 | 0.158 | 39.7 | 390.6 | 33.1 | 3,958.7 | 566.4 | 1 | Chaperone | null | null | null | null | 18 | 4.27 | 360,399 | Fully_covered | 0 | 0 | 3.15 | 0 | 8,374 | Low_value | 0.713 | 0.88 | 0 | 0 | Responder | 0 | null | 0 | 0 | Slow_progression | 7 | 15 | 2 | 1 | 0 | Assisted | Limited_verbal | 1 | 0 | Special_ed | 1 | 1 | 0 | null | null | 0 | 50.4 | 11.8 | 8.9 | 0 | 0 | 5.3 | 26,062 | 54.4 | 56.3 | 97.5 | 48.1 | 59.8 | 45 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 184.1 | 7 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0.73 |
HCG5-0000268 | Male | White_non_Hispanic | North_America | Suburban | High | Other | Commercial | Fabry | LSD | 324 | 301,500 | XLR | 4.9 | 0.04 | 6.73 | 16.663 | 9.933 | 6 | 11 | 6 | 0 | 1 | 0 | 0 | null | WES | 14.34 | 0 | 4,500 | 1 | Neurologist | 6,787.22 | 7.69 | Delayed | 87.6 | 32.6 | 60.3 | 109.4 | 55.9 | 0 | 0 | 0 | 4.17 | 6 | 1 | Severe | 0 | 119.2 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | -1.03 | -2.54 | 1 | 0 | 0 | 0 | 120.06 | 52.995 | 5.372 | 8.33 | 0.27 | 30.1 | 2.8 | 0.134 | 22.7 | 273.4 | 127.5 | 414.4 | 4,819 | 1 | ERT | Agalsidase_alfa | null | null | null | 18 | 4.73 | 148,167 | Partial_coverage | 0 | 0 | 8.88 | 0 | 8,967 | Intermediate | 0.849 | 0.798 | 0 | 0 | Partial | 0 | null | 0 | 0 | Stable | 12 | 28 | 2 | 1 | 0 | Assisted | Limited_verbal | 1 | 0 | Home_school_medical | 1 | 4 | 0 | null | null | 0 | 66 | 5.7 | 18.7 | 1 | 10,614 | 5.4 | 11,066 | 61 | 94.3 | 71.5 | 62.6 | 27.1 | 32.2 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 129.3 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | 0 |
HCG5-0000269 | Female | White_non_Hispanic | Asia_Pacific | Rural | High | English | Commercial | Gaucher_type1 | LSD | 355 | 230,800 | AR | 6.99 | 0.05 | 4.51 | 12.077 | 7.567 | 2 | 17 | 16 | 2 | 0 | 0 | 0 | null | Metabolic | 10.57 | 0 | 900 | 1 | Metabolic_specialist | 26,264.02 | 5.99 | Regression | 15.3 | 65.8 | 46.5 | 69.3 | 14.4 | 0 | 0 | 0 | 5.07 | 8 | 1 | Mild | 0 | 108.7 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | -3.11 | -2.29 | 0 | 0 | 1 | 0 | 158.25 | 12.221 | 8.217 | 2.83 | 2.41 | 20 | 2.29 | 0.198 | 135.1 | 367 | 57.2 | 722.2 | 317.1 | 1 | ASO | null | null | Custom_ASO | null | 12.25 | 15.06 | 556,641 | Partial_coverage | 0 | 0 | 5.3 | 0 | 2,487 | Intermediate | 0.465 | 0.789 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 3 | 10 | 3 | 0 | 0 | Wheelchair | AAC_device | 0 | 0 | Mainstream_with_support | 1 | 4 | 0 | null | null | 0 | 43.6 | 5.6 | 7.1 | 1 | 35,702 | 5.5 | 1,589 | 86.8 | 42.2 | 44.8 | 34.2 | 17.7 | 46.4 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 39.4 | 15 | 1 | 0 | 1 | 1 | 0 | 0 | 6 | 5.13 |
HCG5-0000270 | Male | Other_Multi | Europe | Suburban | Low | Other | Uninsured | Gaucher_type1 | LSD | 355 | 230,800 | AR | 4.85 | 0.05 | 0.01 | 3.316 | 3.306 | 0 | 15 | 3 | 3 | 1 | 0 | 0 | null | null | 15.06 | 0 | 0 | 1 | Metabolic_specialist | 142,391.48 | 7.45 | Delayed | 73.7 | 60.9 | 56.4 | 78.3 | 121.4 | 0 | 0 | 0 | 5.7 | 8 | 0 | null | 0 | 50.2 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | -1.5 | 2.3 | 0 | 0 | 1 | 0 | 236.39 | 22.234 | 36.4 | 2.01 | 3.59 | 20 | 2.81 | 0.134 | 115.1 | 720.9 | 174.8 | 82.1 | 1,862.4 | 1 | ERT | Taliglucerase | null | null | null | 4.27 | 2.22 | 172,879 | Fully_covered | 0 | 0 | 9.8 | 1 | 1,358 | Cost_saving | 0.389 | 0.671 | 0 | 1 | Responder | 0 | null | 0 | 0 | Stable | 1 | 17 | 2 | 1 | 0 | Assisted | Limited_verbal | 0 | 0 | Mainstream_with_support | 0 | 4 | 0 | null | null | 0 | 61.2 | 8.9 | 2.8 | 1 | 300,000 | 5.5 | 9,319 | 50.4 | 42.3 | 67.2 | 63.6 | 48 | 35.6 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 548.2 | 32 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HCG5-0000271 | Female | White_non_Hispanic | Asia_Pacific | Suburban | Middle | English | Uninsured | MPS_I_Hurler | LSD | 579 | 607,014 | AR | 8.4 | 0.8 | 0.008 | 0.008 | 0 | 0 | 4 | 14 | 5 | 0 | 1 | 1 | 3.1 | WES | 1.02 | 0 | 4,500 | 0 | NBS_followup | 26,219.74 | 7.83 | Profound_delay | 83.6 | 11.7 | 32.8 | 66.2 | 46.2 | 1 | 0 | 0 | 1.22 | 8 | 0 | null | 1 | 45.4 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1.67 | -1.09 | 0 | 0 | 1 | 1 | 259.99 | 5.963 | 39.075 | 5.88 | 0.4 | 29.6 | 2.92 | 0.157 | 1,265.9 | 125.8 | 25 | 71.1 | 1,571.7 | 1 | ERT | Laronidase | null | null | null | 2.41 | 33.18 | 261,644 | Prior_auth_required | 0 | 0 | 20.07 | 1 | 11,072 | Low_value | 0.413 | 0.737 | 0 | 0 | Non_responder | 0 | null | 0 | 0 | Moderate | 3 | 18 | 0 | 1 | 0 | Bedbound | Nonverbal | 1 | 1 | Home_school_medical | 1 | 2 | 1 | 11.94 | Cardiac | 0 | 54.2 | 14.7 | 10.1 | 0 | 0 | 8.8 | 15,676 | 36.8 | 33.8 | 24.2 | 3.4 | 29.4 | 41 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 20.5 | 24 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HCG5-0000272 | Female | White_non_Hispanic | Europe | Suburban | High | Spanish | Commercial | Gaucher_type1 | LSD | 355 | 230,800 | AR | 5.98 | 0.05 | 7.114 | 18 | 13.712 | 2 | 4 | 15 | 5 | 0 | 0 | 0 | null | Single_gene | 7.69 | 0 | 800 | 1 | Geneticist | 90,408.5 | 7.7 | Delayed | 57.8 | 44.4 | 20.1 | 44.3 | 97.2 | 0 | 0 | 0 | 2.44 | 1 | 0 | null | 0 | 58.9 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | -1.66 | -2.27 | 1 | 1 | 1 | 0 | 807.7 | 13.865 | 14.145 | 11.59 | 6.09 | 259.1 | 4.86 | 0.093 | 248.3 | 609.8 | 28.5 | 724.9 | 328 | 1 | Chaperone | null | null | null | null | 18 | 6.41 | 1,816,072 | Fully_covered | 0 | 0 | 25.27 | 1 | 4,576 | Low_value | 0.665 | 0.231 | 0 | 0 | Partial | 0 | null | 0 | 0 | Stable | 3 | 19 | 4 | 1 | 0 | Assisted | Limited_verbal | 0 | 0 | Home_school_medical | 1 | 4 | 0 | null | null | 0 | 41 | 15 | 8.9 | 1 | 70,806 | 3.5 | 20,134 | 71.4 | 70.9 | 56.2 | 48.2 | 21.7 | 61.4 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 2 | 41 | 0 | 1 | 1 | 0 | 0 | 0 | 3 | 3.38 |
HCG5-0000273 | Female | Black_non_Hispanic | Latin_America | Suburban | Low | Spanish | Commercial | SMA_type2 | NM | 83,418 | 253,550 | AR | 6.79 | 0.25 | 0.009 | 0.009 | 0 | 0 | 2 | 8 | 8 | 1 | 1 | 1 | 3.3 | Single_gene | 2.64 | 0 | 800 | 0 | NBS_followup | 48,398.66 | 6.8 | Regression | 55.8 | 57.2 | 26.9 | 24.1 | 49 | 0 | 0 | 0 | 4.38 | 1 | 0 | null | 1 | 54.1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -0.86 | -0.48 | 0 | 1 | 0 | 0 | 320.93 | 22.79 | 21.87 | 5.66 | 3.59 | 20 | 2.2 | 0.169 | 590.8 | 663.3 | 38 | 26.1 | 5,373.5 | 1 | Chaperone | null | null | null | null | 0.46 | 18.08 | 414,944 | Partial_coverage | 0 | 0 | 20.23 | 1 | 4,000 | High_value | 0.662 | 0.497 | 0 | 0 | Partial | 0 | null | 0 | 0 | Moderate | 2 | 8 | 1 | 1 | 0 | Wheelchair | AAC_device | 0 | 0 | Mainstream | 1 | 1 | 1 | 7.44 | Other | 1 | 58.5 | 9.9 | 16.7 | 1 | 43,271 | 5.6 | 11,351 | 43.5 | 44.2 | 26.6 | 39.7 | 29.3 | 31.4 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 3.1 | 13 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 4.75 |
HCG5-0000274 | Male | White_non_Hispanic | Europe | Rural | Middle | Spanish | Commercial | MLD | LD | 512 | 250,100 | AR | 9.15 | 0.7 | 0.017 | 0.017 | 0 | 0 | 3 | 17 | 2 | 0 | 1 | 1 | 6.2 | WES | 1.88 | 0 | 4,500 | 1 | NBS_followup | 26,729.37 | 3.46 | Profound_delay | 48.2 | 45.2 | 32.5 | 31.5 | 84.3 | 1 | 0 | 1 | 0.93 | 8 | 0 | null | 0 | 107.8 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | -3.02 | 1.62 | 0 | 0 | 0 | 0 | 83.94 | 29.173 | 10.09 | 2.09 | 3.57 | 38.2 | 2.6 | 0.114 | 314.7 | 310.9 | 19.1 | 290.3 | 2,095.7 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 0.34 | 12.52 | 711,786 | Fully_covered | 0 | 0 | 2.74 | 0 | 1,006 | High_value | 0.377 | 0.398 | 0 | 0 | Partial | 1 | MUD | 1 | 1 | Stable | 0 | 29 | 7 | 0 | 0 | Bedbound | Nonverbal | 1 | 0 | Not_enrolled | 1 | 1 | 1 | 8.11 | Metabolic_crisis | 1 | 62.8 | 5.9 | 12.1 | 1 | 25,648 | 4 | 7,909 | 29.7 | 44.3 | 62.8 | 35.2 | 30.7 | 57.6 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 89.1 | 17 | 1 | 0 | 0 | 0 | 0 | 0 | 11 | 0 |
HCG5-0000275 | Male | White_non_Hispanic | Europe | Urban | Middle | Mandarin | Medicaid_CHIP | OTC | UCD | 664 | 311,250 | XLR | 6.47 | 0.52 | 1.242 | 3.192 | 1.95 | 0 | 14 | 9 | 0 | 0 | 0 | 0 | null | Metabolic | 44.52 | 0 | 900 | 1 | Metabolic_specialist | 23,918.78 | 6.25 | Regression | 67.1 | 74 | 10 | 82.2 | 37.2 | 1 | 0 | 0 | 2.44 | 4 | 0 | null | 0 | 109.5 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -0.99 | -1.62 | 1 | 0 | 0 | 0 | 381.31 | 45.173 | 5.554 | 1.42 | 6.35 | 20 | 1.74 | 0.163 | 1,607.5 | 352.2 | 85.5 | 1,180.5 | 715.3 | 1 | Supportive_only | null | null | null | null | null | 39.63 | 0 | Fully_covered | 0 | 0 | 4.37 | 0 | 15,302 | Intermediate | 0.637 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Moderate | 3 | 16 | 4 | 0 | 0 | Wheelchair | AAC_device | 0 | 0 | Special_ed | 1 | 3 | 0 | null | null | 0 | 43.1 | 8.9 | 15.2 | 0 | 0 | 6 | 3,233 | 69.4 | 33 | 55.9 | 0 | 62.5 | 41.5 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 4.5 | 4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 3.11 |
HCG5-0000276 | Female | White_non_Hispanic | Asia_Pacific | Suburban | Middle | English | Commercial | PA | OA | 35 | 606,054 | AR | 5.97 | 0.5 | 0.011 | 0.011 | 0 | 0 | 2 | 17 | 0 | 0 | 1 | 1 | 4.1 | Panel | 1.81 | 1 | 1,500 | 0 | NBS_followup | 3,994.26 | 7.16 | Delayed | 53.8 | 78.3 | 16 | 48.6 | 69.2 | 0 | 0 | 0 | 3.22 | 1 | 0 | null | 0 | 93.9 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | -1.78 | -0.47 | 1 | 1 | 1 | 0 | 31.57 | 92.262 | 3.156 | 3.31 | 2.29 | 20 | 2.38 | 0.107 | 83.9 | 390.8 | 42.4 | 535.8 | 2,511.4 | 0 | Supportive_only | null | null | null | null | null | 0.96 | 0 | Fully_covered | 0 | 0 | 16.54 | 0 | 1,147 | Intermediate | 0.449 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 4 | 22 | 3 | 1 | 1 | Assisted | Limited_verbal | 0 | 1 | Mainstream_with_support | 1 | 1 | 1 | 14.74 | Respiratory_failure | 1 | 36.7 | 12.1 | 0 | 0 | 0 | 4.1 | 5,090 | 79.4 | 42.5 | 75.6 | 43 | 28.5 | 54.1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 27.2 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.91 |
HCG5-0000277 | Male | White_non_Hispanic | Europe | Urban | Middle | English | Medicaid | MERRF | MITO | 551 | 545,000 | MT | 6.65 | 0.22 | 9.537 | 12.891 | 3.354 | 2 | 8 | 16 | 2 | 0 | 0 | 0 | null | Single_gene | 9.05 | 1 | 800 | 1 | NBS_followup | 20,187.11 | 6.88 | Regression | 38.6 | 29.4 | 46.5 | 65.6 | 37.4 | 0 | 0 | 1 | 1.68 | 8 | 0 | null | 0 | 78.6 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | -2.75 | -3.37 | 0 | 1 | 0 | 0 | 123.15 | 14.999 | 16.291 | 5.77 | 3.45 | 134.5 | 1.91 | 0.164 | 220.2 | 526.8 | 20 | 532 | 4,464.2 | 0 | Supportive_only | null | null | null | null | null | 39.9 | 0 | Fully_covered | 0 | 0 | 11.52 | 0 | 717 | Intermediate | 0.288 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Rapid | 2 | 30 | 4 | 0 | 1 | Wheelchair | AAC_device | 0 | 0 | Mainstream_with_support | 1 | 4 | 0 | null | null | 0 | 24.7 | 3.6 | 9 | 1 | 38,143 | 5.7 | 16,614 | 44.5 | 65.7 | 72.8 | 60.5 | 50 | 35.5 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 187.2 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 1 |
HCG5-0000278 | Female | Hispanic | North_America | Rural | Low | English | Commercial | EB_dystrophic | DERM | 305 | 131,750 | AD | 6.72 | 0.18 | 0.14 | 2.46 | 2.32 | 6 | 13 | 9 | 2 | 1 | 0 | 0 | null | Panel | 20.43 | 0 | 1,500 | 1 | Geneticist | 33,156.59 | 3.51 | Regression | 68.1 | 65.5 | 50.3 | 67.2 | 118.2 | 0 | 0 | 1 | 3.25 | 0 | 0 | null | 1 | 52.9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.39 | -1.15 | 1 | 0 | 0 | 0 | 135.6 | 62.196 | 27.394 | 3.08 | 7.23 | 20 | 1.09 | 0.237 | 37.2 | 253.4 | 25.1 | 231.7 | 308.3 | 0 | Supportive_only | null | null | null | null | null | 38.94 | 0 | Denied | 1 | 0 | 5.28 | 0 | 1,147 | Cost_saving | 0.392 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Slow_progression | 0 | 14 | 0 | 0 | 0 | Wheelchair | AAC_device | 0 | 0 | Special_ed | 1 | 6 | 0 | null | null | 0 | 53.2 | 14.1 | 18.1 | 1 | 47,574 | 4.9 | 2,630 | 52.6 | 17 | 48 | 37.3 | 7.6 | 46.8 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 3.4 | 13 | 1 | 0 | 1 | 1 | 0 | 0 | 2 | 4.65 |
HCG5-0000279 | Female | Black_non_Hispanic | Europe | Suburban | Low | English | Uninsured | HLH | IMM | 540 | 267,700 | AR | 8.03 | 0.8 | 0.506 | 1.668 | 1.162 | 4 | 10 | 10 | 0 | 1 | 0 | 0 | null | Panel | 1.52 | 0 | 1,500 | 1 | Geneticist | 33,140.01 | 6.21 | Profound_delay | 13.5 | 64.1 | 37.2 | 52.5 | 47.9 | 0 | 0 | 0 | 2.33 | 8 | 0 | null | 0 | 103 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0.47 | 1.2 | 0 | 0 | 0 | 0 | 350.13 | 28.235 | 7.694 | 10.04 | 3.49 | 25.3 | 3.76 | 0.13 | 647.9 | 362.4 | 24.3 | 155.9 | 100 | 0 | Supportive_only | null | null | null | null | null | 13.59 | 0 | Prior_auth_required | 0 | 0 | 2.93 | 0 | 673 | High_value | 0.727 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Rapid | 5 | 29 | 1 | 1 | 0 | Bedbound | Nonverbal | 1 | 1 | Mainstream | 1 | 5 | 0 | null | null | 1 | 40.4 | 23.1 | 5.6 | 0 | 0 | 7.1 | 2,533 | 65.9 | 6.7 | 75.2 | 61.5 | 40.1 | 37.6 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 41.9 | 18 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 0.73 |
HCG5-0000280 | Male | White_non_Hispanic | North_America | Urban | Low | Spanish | Medicaid | Gaucher_type1 | LSD | 355 | 230,800 | AR | 5.15 | 0.05 | 1.317 | 5.761 | 4.443 | 2 | 8 | 4 | 1 | 1 | 0 | 0 | null | null | 90.35 | 0 | 0 | 1 | Other | 247,526.49 | 5.56 | Delayed | 81.5 | 72.3 | 14 | 42.3 | 88.4 | 1 | 1 | 0 | 1.06 | 8 | 0 | null | 1 | 106.6 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | -1.88 | -1.65 | 0 | 0 | 1 | 0 | 1,065.08 | 6.844 | 35.473 | 6.83 | 0.63 | 44.6 | 5.44 | 0.114 | 931.5 | 347.3 | 85.3 | 2,618.2 | 1,733.7 | 1 | ERT | Taliglucerase | null | null | null | 6.46 | 17.7 | 168,728 | Prior_auth_required | 0 | 0 | 0.2 | 1 | 444 | Intermediate | 0.55 | 0.516 | 1 | 1 | Non_responder | 0 | null | 0 | 0 | Slow_progression | 3 | 20 | 1 | 0 | 0 | Assisted | Limited_verbal | 0 | 0 | Special_ed | 1 | 1 | 0 | null | null | 0 | 53.4 | 7.7 | 8.9 | 0 | 0 | 4 | 12,522 | 43.5 | 40.8 | 39.2 | 76.6 | 68.3 | 53.8 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 50.3 | 9 | 0 | 0 | 0 | 1 | 1 | 0 | 4 | 3.74 |
HCG5-0000281 | Female | White_non_Hispanic | Asia_Pacific | Urban | Low | English | Commercial | MPS_I_Hurler | LSD | 579 | 607,014 | AR | 8.75 | 0.8 | 0.016 | 0.016 | 0 | 0 | 4 | 14 | 1 | 1 | 1 | 1 | 5.7 | WES | 1.45 | 1 | 4,500 | 1 | NBS_followup | 34,643.39 | 8.44 | Profound_delay | 36.1 | 55.3 | 71.3 | 49.6 | 59.2 | 0 | 1 | 0 | 2.73 | 1 | 0 | null | 1 | 28.9 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | -2.23 | -2.44 | 0 | 0 | 0 | 1 | 225.36 | 19.388 | 8.615 | 5.42 | 3.48 | 97.7 | 2.18 | 0.226 | 697.4 | 512.6 | 61.6 | 950.5 | 838.6 | 1 | ERT | Laronidase | null | null | null | 0.27 | 19.22 | 1,134,658 | Partial_coverage | 0 | 0 | 1.59 | 0 | 4,098 | Intermediate | 0.329 | 0.792 | 0 | 1 | Responder | 1 | MUD | 0 | 1 | Stable | 2 | 17 | 0 | 0 | 1 | Bedbound | Nonverbal | 1 | 0 | Home_school_medical | 1 | 2 | 0 | null | null | 0 | 53.1 | 26.3 | 15.4 | 1 | 240,152 | 4.2 | 8,933 | 65 | 32 | 100 | 56.5 | 32.6 | 22.7 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 10 | 10 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 2.44 |
HCG5-0000282 | Male | White_non_Hispanic | North_America | Urban | Middle | English | Uninsured | MPS_IV_Morquio | LSD | 582 | 253,000 | AR | 5.65 | 0.3 | 3.003 | 15.198 | 12.194 | 4 | 5 | 15 | 1 | 1 | 0 | 0 | null | Single_gene | 97.95 | 0 | 800 | 0 | Geneticist | 47,435.72 | 6.94 | Delayed | 63.3 | 28.3 | 30.3 | 55.3 | 66.7 | 0 | 0 | 0 | 4.42 | 0 | 0 | null | 1 | 90 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | -3.17 | -1.64 | 0 | 0 | 1 | 1 | 126.3 | 24.638 | 13.136 | 6.73 | 3.52 | 20 | 2.72 | 0.238 | 210.7 | 1,390.9 | 40.7 | 620.7 | 6,894.6 | 1 | Small_molecule | null | null | null | Supportive_metabolic | 15.31 | 3.7 | 684,916 | Partial_coverage | 0 | 0 | 5.08 | 1 | 353 | High_value | 0.589 | 0.847 | 0 | 0 | Partial | 0 | null | 0 | 0 | Rapid | 7 | 27 | 0 | 1 | 1 | Assisted | Limited_verbal | 0 | 0 | Special_ed | 0 | 5 | 1 | 18 | Neurodegeneration | 1 | 51.4 | 8.5 | 7.9 | 1 | 9,373 | 4.4 | 26,447 | 81.9 | 43.9 | 35.2 | 65.1 | 62.6 | 47.9 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 72.1 | 17 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HCG5-0000283 | Female | Black_non_Hispanic | North_America | Suburban | Middle | English | Medicaid | MPS_VI_Maroteaux | LSD | 583 | 253,200 | AR | 6.38 | 0.32 | 2.622 | 8.572 | 5.95 | 3 | 17 | 14 | 2 | 1 | 0 | 0 | null | Panel | 4.62 | 0 | 1,500 | 0 | Metabolic_specialist | 76,762.14 | 7.65 | Regression | 49.1 | 41.6 | 38.2 | 90.9 | 74.4 | 0 | 0 | 0 | 1.22 | 0 | 0 | null | 0 | 93.4 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | -0.49 | -1.38 | 0 | 0 | 1 | 1 | 90.17 | 10.454 | 9.985 | 1.48 | 7.47 | 213.8 | 3.73 | 0.196 | 41 | 252.9 | 34.6 | 252.3 | 1,248.4 | 1 | ERT | Galsulfase | null | null | null | 9.01 | 10.59 | 29,099 | Prior_auth_required | 0 | 0 | 5.15 | 0 | 3,116 | High_value | 0.549 | 0.613 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 3 | 26 | 2 | 0 | 0 | Wheelchair | AAC_device | 0 | 0 | Home_school_medical | 1 | 4 | 0 | null | null | 0 | 44.8 | 11.6 | 14.5 | 1 | 24,334 | 6.2 | 15,193 | 31.8 | 42.2 | 73.4 | 61.2 | 6.9 | 28.9 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 44.1 | 20 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 2.51 |
HCG5-0000284 | Female | Asian | North_America | Urban | Low | English | Commercial | SMA_type2 | NM | 83,418 | 253,550 | AR | 7.26 | 0.25 | 0.029 | 0.029 | 0 | 0 | 3 | 13 | 2 | 1 | 1 | 1 | 10.7 | Single_gene | 0.36 | 1 | 800 | 1 | NBS_followup | 43,758.94 | 6.22 | Regression | 78.6 | 80.9 | 22.7 | 74.4 | 87.8 | 0 | 0 | 0 | 1.62 | 2 | 0 | null | 1 | 73 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | -0.59 | 0.82 | 0 | 0 | 0 | 0 | 417.82 | 8.701 | 37.07 | 3.01 | 2.44 | 20 | 2.04 | 0.137 | 220.6 | 379.7 | 37.8 | 128.7 | 2,463.7 | 1 | Gene_therapy | null | Onasemnogene_abeparvovec | null | null | 0.55 | 26.55 | 2,413,530 | Partial_coverage | 0 | 0 | 9.68 | 0 | 290 | Low_value | 0.364 | 0.662 | 0 | 0 | Partial | 0 | null | 0 | 0 | Slow_progression | 3 | 22 | 0 | 0 | 0 | Wheelchair | AAC_device | 1 | 0 | Special_ed | 0 | 5 | 0 | null | null | 0 | 30 | 16.1 | 7.8 | 1 | 105,768 | 6 | 3,520 | 27.7 | 44.6 | 81.1 | 64.8 | 22.3 | 40.2 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 107.3 | 12 | 1 | 0 | 0 | 0 | 0 | 0 | 5 | 1.07 |
HCG5-0000285 | Male | Asian | Asia_Pacific | Urban | Middle | Spanish | Uninsured | CPS1 | UCD | 147 | 237,300 | AR | 7.27 | 0.62 | 0.01 | 1.877 | 1.867 | 4 | 19 | 12 | 5 | 1 | 0 | 0 | null | WES | 15.89 | 0 | 4,500 | 0 | Neurologist | 24,898.33 | 7.83 | Regression | 57.2 | 49.6 | 76.4 | 45.4 | 72.5 | 0 | 0 | 0 | 2.56 | 0 | 0 | null | 0 | 92.1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | -0.82 | 0.21 | 1 | 0 | 0 | 0 | 149.18 | 8.442 | 18.98 | 1.95 | 1.38 | 72.1 | 2.49 | 0.128 | 108.5 | 249.5 | 155.5 | 802.4 | 1,499.7 | 1 | HSCT | null | null | null | null | 3.21 | 1.4 | 733,253 | Denied | 1 | 1 | 11.49 | 0 | 132 | Cost_saving | 0.286 | 0.794 | 0 | 0 | Partial | 0 | null | 0 | 0 | Slow_progression | 5 | 17 | 3 | 0 | 0 | Wheelchair | AAC_device | 1 | 0 | Special_ed | 1 | 6 | 1 | 14.01 | Cardiac | 1 | 54.4 | 12.9 | 10.6 | 0 | 0 | 5.4 | 28,763 | 22.8 | 36 | 60.9 | 40.4 | 59.2 | 45.3 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 51.6 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 |
HCG5-0000286 | Female | White_non_Hispanic | North_America | Rural | Middle | Spanish | Uninsured | Gaucher_type1 | LSD | 355 | 230,800 | AR | 4.28 | 0.05 | 7.333 | 13.339 | 6.007 | 3 | 9 | 14 | 2 | 1 | 0 | 0 | null | WES | 15.84 | 0 | 4,500 | 1 | Geneticist | 25,007.51 | 7.28 | Delayed | 66.4 | 115.7 | 78.9 | 105.8 | 78.8 | 0 | 0 | 0 | 2.74 | 1 | 0 | null | 0 | 118.9 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | -1.87 | 0.52 | 0 | 0 | 0 | 0 | 109.6 | 13.61 | 11.559 | 6.1 | 1.38 | 28.1 | 1.95 | 0.145 | 740.4 | 285.9 | 37.9 | 174.6 | 385.3 | 1 | ERT | Imiglucerase | null | null | null | 15.05 | 16.75 | 1,275,776 | Fully_covered | 0 | 0 | 36 | 1 | 6,363 | High_value | 0.22 | 0.384 | 0 | 0 | Responder | 0 | null | 0 | 0 | Slow_progression | 4 | 11 | 5 | 0 | 0 | Assisted | Limited_verbal | 0 | 0 | Mainstream_with_support | 1 | 5 | 0 | null | null | 0 | 57.2 | 2.1 | 13.4 | 1 | 45,099 | 6.5 | 8,306 | 50 | 80.5 | 43.8 | 43.3 | 68.2 | 59.7 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 31.9 | 26 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 0.19 |
HCG5-0000287 | Male | White_non_Hispanic | Asia_Pacific | Suburban | Middle | English | Medicaid | HCU_homocystinuria | OA | 394 | 236,200 | AR | 6.14 | 0.08 | 0.006 | 0.006 | 0 | 0 | 3 | 8 | 0 | 0 | 1 | 1 | 2 | Single_gene | 1.55 | 0 | 800 | 1 | NBS_followup | 19,622.08 | 6.99 | Regression | 53.8 | 37.6 | 47.1 | 66.6 | 75.8 | 1 | 0 | 0 | 2.29 | 3 | 0 | null | 0 | 95.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.9 | -0.35 | 1 | 1 | 0 | 0 | 469.32 | 10.194 | 13.052 | 1.97 | 12.16 | 103.3 | 1.6 | 0.161 | 146.6 | 213.2 | 81.5 | 266.8 | 1,864.1 | 0 | Supportive_only | null | null | null | null | null | 10.98 | 0 | Partial_coverage | 0 | 0 | 3.34 | 0 | 173 | Intermediate | 0.124 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Stable | 3 | 24 | 2 | 1 | 0 | Wheelchair | AAC_device | 0 | 0 | Special_ed | 1 | 6 | 0 | null | null | 0 | 79.5 | 14.3 | 5.1 | 1 | 18,182 | 3.1 | 12,407 | 32 | 64.1 | 45 | 39.7 | 90.8 | 22.7 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 81.3 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | 0.1 |
HCG5-0000288 | Male | White_non_Hispanic | Asia_Pacific | Urban | High | English | Medicaid | Barth_syndrome | MITO | 111 | 302,060 | XLR | 6.97 | 0.35 | 0.97 | 8.234 | 7.264 | 7 | 4 | 27 | 0 | 0 | 0 | 0 | null | Panel | 13.27 | 0 | 1,500 | 1 | Geneticist | 40,126.41 | 8.51 | Regression | 52 | 86.5 | 39.8 | 22.9 | 101.7 | 0 | 0 | 0 | 4.39 | 5 | 1 | Moderate | 0 | 73.7 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | -2.79 | -1.39 | 0 | 0 | 0 | 0 | 583.63 | 67.179 | 4.179 | 4.79 | 4.31 | 625.5 | 3.04 | 0.083 | 142.9 | 169.8 | 35.5 | 481.7 | 480 | 1 | Small_molecule | null | null | null | Elamipretide | 8.51 | 19.89 | 70,021 | Partial_coverage | 0 | 0 | 1.15 | 1 | 4,954 | Intermediate | 0.302 | 0.661 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 3 | 16 | 0 | 0 | 0 | Wheelchair | AAC_device | 0 | 0 | Not_enrolled | 1 | 2 | 0 | null | null | 0 | 39.3 | 13.6 | 6.7 | 1 | 12,609 | 5.5 | 4,312 | 72.1 | 42.8 | 38.6 | 67.9 | 63.1 | 20.4 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 220.7 | 13 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2.44 |
HCG5-0000289 | Male | Black_non_Hispanic | North_America | Urban | Middle | English | Commercial | Fabry | LSD | 324 | 301,500 | XLR | 4.43 | 0.04 | 0.582 | 6.138 | 5.557 | 1 | 6 | 12 | 4 | 0 | 0 | 0 | null | MLPA | 5.88 | 0 | 1,000 | 0 | Other | 23,079.76 | 8.25 | Delayed | 114.4 | 60.9 | 72.8 | 69.7 | 65.2 | 0 | 0 | 0 | 2.48 | 6 | 1 | Moderate | 1 | 64.9 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | -1.54 | -1.64 | 0 | 0 | 0 | 0 | 69.45 | 2.445 | 1.632 | 3.93 | 11.62 | 24.8 | 3.03 | 0.112 | 3,323.5 | 659.5 | 145.1 | 308.1 | 457.1 | 1 | Gene_therapy | null | Clinical_trial | null | null | 6.54 | 2.46 | 84,419 | Fully_covered | 0 | 0 | 2.9 | 0 | 3,419 | Intermediate | 0.388 | 0.688 | 0 | 0 | Responder | 0 | null | 0 | 0 | Moderate | 0 | 11 | 5 | 0 | 0 | Assisted | Limited_verbal | 1 | 0 | Mainstream | 1 | 4 | 0 | null | null | 0 | 30.9 | 10.8 | 14.7 | 1 | 25,971 | 5.8 | 10,248 | 41.6 | 71 | 63 | 43.2 | 79.4 | 66.3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 249.2 | 16 | 1 | 0 | 0 | 0 | 0 | 0 | 5 | 0 |
HCG5-0000290 | Male | White_non_Hispanic | Asia_Pacific | Rural | High | English | Medicaid | CGD | IMM | 379 | 306,400 | XLR | 5.42 | 0.25 | 0.01 | 11.818 | 11.808 | 1 | 7 | 19 | 0 | 0 | 0 | 0 | null | WGS | 2.5 | 0 | 8,500 | 1 | Geneticist | 47,213.86 | 8.18 | Delayed | 41.1 | 82.8 | 35.9 | 95.9 | 27.8 | 0 | 1 | 1 | 6.65 | 2 | 0 | null | 0 | 112.8 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -1.87 | 0.29 | 0 | 0 | 0 | 0 | 40.59 | 24.536 | 7.551 | 7.24 | 13.23 | 35.8 | 3.87 | 0.273 | 638.5 | 436.2 | 19 | 1,346.1 | 603.3 | 1 | HSCT | null | null | null | null | 16.6 | 4.4 | 2,368,987 | Fully_covered | 0 | 0 | 30.24 | 1 | 3,313 | High_value | 0.647 | 0.614 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 8 | 49 | 1 | 0 | 0 | Assisted | Limited_verbal | 1 | 0 | Mainstream | 1 | 2 | 0 | null | null | 0 | 30 | 13.1 | 6.4 | 1 | 71,858 | 6 | 3,651 | 49.1 | 0 | 76.2 | 52 | 30.4 | 43.6 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 105.5 | 18 | 1 | 0 | 0 | 0 | 0 | 1 | 6 | 0.73 |
HCG5-0000291 | Male | Black_non_Hispanic | North_America | Suburban | Low | Spanish | Medicaid | Gaucher_type1 | LSD | 355 | 230,800 | AR | 3.78 | 0.05 | 4.455 | 9.375 | 4.921 | 1 | 8 | 14 | 2 | 1 | 0 | 0 | null | WES | 14.63 | 1 | 4,500 | 0 | Geneticist | 10,848.93 | 6.61 | Delayed | 94.9 | 70.9 | 81.5 | 59.8 | 53.9 | 1 | 1 | 0 | 5.74 | 1 | 0 | null | 0 | 88 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | -1.48 | 2.14 | 0 | 1 | 0 | 0 | 164.39 | 35.712 | 10.231 | 1.72 | 1.7 | 20 | 2.22 | 0.18 | 889.9 | 382.4 | 78.6 | 57.3 | 552.6 | 1 | ERT | Velaglucerase | null | null | null | 11.04 | 2.15 | 60,475 | Denied | 0 | 0 | 6.76 | 1 | 1,121 | Intermediate | 0.568 | 0.769 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 6 | 26 | 0 | 0 | 0 | Ambulatory | Verbal | 0 | 0 | Special_ed | 1 | 3 | 0 | null | null | 0 | 44.3 | 14.8 | 10.6 | 1 | 24,216 | 5.9 | 735 | 67 | 61.5 | 73.6 | 52.9 | 55.4 | 19.9 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 134.8 | 26 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0.56 |
HCG5-0000292 | Female | Black_non_Hispanic | North_America | Suburban | Middle | English | Medicaid | CDKL5_encephalopathy | SYN | 3,095 | 300,672 | XLD | 8.34 | 0.22 | 0.057 | 7.825 | 7.768 | 1 | 13 | 31 | 1 | 0 | 0 | 0 | null | WES | 3.06 | 0 | 4,500 | 1 | Neurologist | 30,704.47 | 8.68 | Profound_delay | 56 | 50.5 | 30.1 | 44.5 | 29.1 | 1 | 0 | 1 | 2.95 | 4 | 0 | null | 0 | 42.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -3.98 | -1.91 | 0 | 1 | 1 | 0 | 57.96 | 9.332 | 19.651 | 6.43 | 1.59 | 20 | 1.08 | 0.27 | 132.4 | 235.8 | 26.3 | 263.5 | 1,464.9 | 0 | Supportive_only | null | null | null | null | null | 2.12 | 0 | Partial_coverage | 0 | 0 | 16.63 | 0 | 674 | High_value | 0.455 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Rapid | 3 | 26 | 0 | 0 | 0 | Bedbound | Nonverbal | 1 | 0 | Not_enrolled | 1 | 3 | 0 | null | null | 0 | 59.9 | 8.2 | 16 | 1 | 36,522 | 6.1 | 37,915 | 34.3 | 58.2 | 56.4 | 54.9 | 13.8 | 44.7 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 26.5 | 18 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 2.33 |
HCG5-0000293 | Male | White_non_Hispanic | Asia_Pacific | Urban | High | English | Medicaid | Fabry | LSD | 324 | 301,500 | XLR | 7.43 | 0.04 | 0.01 | 4.425 | 4.415 | 3 | 15 | 17 | 5 | 1 | 0 | 0 | null | null | 2.78 | 0 | 0 | 1 | Geneticist | 108,755.83 | 9.41 | Regression | 79.4 | 65.2 | 58.9 | 25.9 | 37.5 | 0 | 0 | 0 | 2.47 | 0 | 1 | Mild | 0 | 85.5 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0.44 | -2.03 | 0 | 1 | 1 | 0 | 50.55 | 18.016 | 10.519 | 1.9 | 2.96 | 20 | 4.33 | 0.248 | 65.3 | 351.6 | 210.5 | 2,570.5 | 1,221.7 | 1 | ERT | Agalsidase_beta | null | null | null | 10.29 | 24.88 | 225,007 | Fully_covered | 0 | 0 | 4.03 | 1 | 1,076 | High_value | 0.083 | 0.785 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 2 | 25 | 0 | 0 | 0 | Wheelchair | AAC_device | 1 | 0 | Special_ed | 1 | 5 | 0 | null | null | 0 | 60.4 | 16.4 | 11.3 | 1 | 26,271 | 6.3 | 2,593 | 51.6 | 32.5 | 30.6 | 65.9 | 70.3 | 43.1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 40.9 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 7 | 0.58 |
HCG5-0000294 | Male | White_non_Hispanic | Latin_America | Urban | High | English | Commercial | HLH | IMM | 540 | 267,700 | AR | 9.68 | 0.8 | 1.232 | 1.353 | 0.121 | 1 | 6 | 8 | 0 | 1 | 0 | 0 | null | WES | 7.53 | 0 | 4,500 | 1 | Neurologist | 21,978.91 | 4.65 | Profound_delay | 48.4 | 28.3 | 42.4 | 14.3 | 25.2 | 0 | 0 | 0 | 3.3 | 1 | 0 | null | 1 | 57.2 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0.14 | -2.22 | 0 | 1 | 0 | 0 | 64.03 | 16.315 | 7.986 | 2.07 | 5.77 | 35.7 | 1.43 | 0.146 | 880.2 | 204.8 | 72.8 | 656.4 | 2,402.2 | 0 | Supportive_only | null | null | null | null | null | 5.22 | 0 | Denied | 0 | 0 | 4.26 | 0 | 3,037 | High_value | 0.473 | null | 0 | 0 | Not_applicable | 1 | Haplo | 0 | 1 | Slow_progression | 13 | 26 | 5 | 0 | 0 | Bedbound | Nonverbal | 1 | 0 | Mainstream_with_support | 1 | 4 | 1 | 8.97 | Other | 1 | 71.7 | 10.2 | 12.8 | 0 | 0 | 8.1 | 3,528 | 57.4 | 47.7 | 85 | 60.9 | 34.4 | 43.3 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 91.4 | 5 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | 2.19 |
HCG5-0000295 | Female | White_non_Hispanic | North_America | Urban | Middle | Other | Commercial | Rett | SYN | 778 | 312,750 | XLD | 5.9 | 0.12 | 2.472 | 8.55 | 6.078 | 2 | 13 | 17 | 2 | 0 | 0 | 0 | null | Metabolic | 16.96 | 0 | 900 | 0 | Geneticist | 141,308.6 | 3.08 | Delayed | 61.7 | 78.6 | 46.2 | 45.8 | 65.3 | 1 | 0 | 1 | 3.34 | 2 | 1 | Mild | 0 | 87 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | -3.18 | 0.93 | 0 | 0 | 0 | 0 | 516.22 | 20.705 | 0.858 | 4 | 0.94 | 20 | 1.42 | 0.147 | 1,466.3 | 360.1 | 13.6 | 197 | 374.6 | 0 | Small_molecule | null | null | null | Supportive_metabolic | 10.6 | 4.81 | 651,123 | Denied | 1 | 1 | 1.43 | 1 | 1,372 | Low_value | 0.124 | 0.48 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 5 | 43 | 0 | 1 | 0 | Assisted | Limited_verbal | 0 | 0 | Not_enrolled | 1 | 6 | 0 | null | null | 0 | 52.1 | 22 | 18.2 | 0 | 0 | 6.6 | 3,309 | 100 | 35.7 | 56.9 | 21 | 60.9 | 53.1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 71.6 | 13 | 1 | 1 | 0 | 0 | 0 | 0 | 10 | 0.79 |
HCG5-0000296 | Male | White_non_Hispanic | Europe | Suburban | Middle | Spanish | Commercial | 22q11_2_DiGeorge | SYN | 567 | 188,400 | AD | 5.85 | 0.08 | 0.617 | 4.506 | 3.889 | 4 | 13 | 11 | 2 | 1 | 0 | 0 | null | Single_gene | 80.46 | 0 | 800 | 0 | Metabolic_specialist | 31,172.9 | 8.88 | Delayed | 80.3 | 58.7 | 16 | 38.7 | 71.5 | 1 | 0 | 0 | 2.24 | 7 | 1 | Mild | 0 | 77.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.11 | -0.47 | 0 | 0 | 0 | 0 | 347.37 | 40.312 | 19.579 | 11.65 | 5 | 20 | 1.62 | 0.243 | 52.3 | 431.3 | 23.3 | 589.2 | 1,405.7 | 0 | Supportive_only | null | null | null | null | null | 33.1 | 0 | Partial_coverage | 0 | 0 | 4.96 | 0 | 572 | Intermediate | 0.577 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Rapid | 5 | 10 | 2 | 1 | 0 | Assisted | Limited_verbal | 0 | 0 | Mainstream_with_support | 1 | 4 | 0 | null | null | 0 | 29.9 | 19 | 21 | 1 | 35,864 | 4 | 38,128 | 62.2 | 55.2 | 53.1 | 63.8 | 0 | 22.3 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 106.9 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 3 | 2.76 |
HCG5-0000297 | Male | White_non_Hispanic | North_America | Urban | Middle | English | Commercial | Diastrophic | SKEL | 628 | 222,600 | AR | 4.59 | 0.1 | 0.045 | 0.278 | 0.233 | 1 | 9 | 13 | 3 | 0 | 0 | 0 | null | Panel | 29.35 | 1 | 1,500 | 1 | Geneticist | 25,569.17 | 6.58 | Delayed | 74.3 | 74.9 | 62.7 | 58.4 | 78.6 | 0 | 0 | 1 | 2.86 | 2 | 0 | null | 0 | 117.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -3.58 | 0.49 | 0 | 0 | 0 | 0 | 2,116.41 | 37.19 | 14.73 | 2.29 | 4.78 | 20 | 0.78 | 0.224 | 131.5 | 278.3 | 72.2 | 232.2 | 1,117.3 | 0 | HSCT | null | null | null | null | 2.87 | 6.84 | 570,950 | Fully_covered | 0 | 0 | 6.75 | 0 | 7,651 | Intermediate | 0.582 | 0.653 | 0 | 0 | Responder | 0 | null | 0 | 0 | Moderate | 7 | 21 | 0 | 1 | 0 | Assisted | Limited_verbal | 0 | 0 | Mainstream_with_support | 0 | 1 | 0 | null | null | 1 | 49 | 6.4 | 10.8 | 1 | 29,682 | 6.8 | 10,061 | 30.1 | 26.2 | 67.2 | 58.7 | 0 | 49.1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 266.7 | 7 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 1.98 |
HCG5-0000298 | Female | Hispanic | Europe | Urban | Middle | English | Medicaid_CHIP | Achondroplasia | SKEL | 15 | 100,800 | AD | 3.99 | 0.04 | 0.05 | 0.852 | 0.802 | 0 | 4 | 9 | 0 | 0 | 0 | 0 | null | Single_gene | 46.21 | 0 | 800 | 1 | Metabolic_specialist | 29,880.36 | 4.42 | Delayed | 87.6 | 25 | 41.6 | 107.1 | 60.8 | 0 | 0 | 1 | 6.6 | 1 | 0 | null | 0 | 35.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.7 | -1.21 | 0 | 0 | 1 | 0 | 95.4 | 12.936 | 25.342 | 1.08 | 1.21 | 254.4 | 1.95 | 0.245 | 81.7 | 250 | 70.8 | 1,227.8 | 2,211.4 | 0 | Supportive_only | null | null | null | null | null | 28.79 | 0 | Fully_covered | 0 | 0 | 14.6 | 0 | 339 | Low_value | 0.429 | null | 0 | 0 | Not_applicable | 0 | null | 0 | 0 | Rapid | 0 | 21 | 0 | 0 | 0 | Ambulatory | Verbal | 0 | 0 | Mainstream_with_support | 0 | 3 | 0 | null | null | 0 | 15.8 | 19.6 | 7.9 | 1 | 18,942 | 5.6 | 11,696 | 72.4 | 72.1 | 32.5 | 64.4 | 93.8 | 40.4 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 48.1 | 37 | 0 | 0 | 0 | 0 | 0 | 1 | 7 | 2.42 |
HCG5-0000299 | Female | White_non_Hispanic | Europe | Suburban | Middle | English | Medicaid | Congenital_myopathy | NM | 97,245 | 160,150 | AR | 5.79 | 0.18 | 1.033 | 4.056 | 3.024 | 1 | 8 | 16 | 1 | 1 | 0 | 0 | null | Karyotype | 21.19 | 0 | 1,200 | 1 | Geneticist | 20,327.28 | 5.22 | Delayed | 88.1 | 57.7 | 61.1 | 61.7 | 88.3 | 1 | 0 | 1 | 0.64 | 7 | 0 | null | 1 | 57.1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -4.43 | 0.59 | 1 | 0 | 0 | 0 | 685.29 | 5.732 | 12.485 | 2.1 | 1.24 | 365.5 | 3.23 | 0.164 | 436 | 285.4 | 67.2 | 603.9 | 2,320.1 | 0 | Small_molecule | null | null | null | Supportive_metabolic | 4.14 | 3.14 | 497,642 | Prior_auth_required | 0 | 0 | 11.08 | 1 | 220 | High_value | 0.567 | 0.841 | 0 | 0 | Responder | 0 | null | 0 | 0 | Stable | 7 | 3 | 2 | 1 | 0 | Assisted | Limited_verbal | 0 | 0 | Special_ed | 1 | 2 | 0 | null | null | 0 | 41.8 | 15.2 | 14.6 | 0 | 0 | 5.1 | 16,326 | 61 | 48.7 | 59.3 | 50.2 | 100 | 48.3 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 10.7 | 23 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.